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There is grandeur in this view of life, with
its several powers, having been originally
breathed into a few forms or into one; and
that, whilst this planet has gone cycling on
according to the fixed law of gravity, from
so simple a beginning endless forms most
beautiful and most wonderful have been,
and are being, evolved.
Charles Darwin, The Origin of Species
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SUMMARY
Extraintestinal pathogenic Escherichia coli (ExPEC) represent a diverse group of strains of E. coli,
which infect extraintestinal sites, such as the urinary tract, the bloodstream, the meninges, the
peritoneal cavity, and the lungs (Russo and Johnson, 2003). Urinary tract infections (UTIs) caused by
uropathogenic E. coli (UPEC), the major subgroup of ExPEC, are among the most prevalent microbial
diseases world wide and a substantial burden for public health care systems (Foxman and Brown,
2003; Russo and Johnson, 2003). UTIs are responsible for serious morbidity and mortality in the
elderly, in young children, and in immune-compromised and hospitalized patients (Bagshaw and
Laupland, 2006; Foxman and Brown, 2003; Scholes et al., 2005; Tambyah et al., 2002).
ExPEC strains are different, both from genetic and clinical perspectives, from commensal E.
coli strains belonging to the normal intestinal flora and from intestinal pathogenic E. coli strains
causing diarrhea (Caprioli et al., 2005; Johnson and Russo, 2005; Nataro, 2005). ExPEC strains are
characterized by a broad range of alternate virulence factors, such as adhesins, toxins, and iron
accumulation systems (Hochhut et al., 2005; Johnson et al., 2005b; Johnson et al. 2005d; Russo and
Johnson, 2003). Unlike diarrheagenic E. coli, whose distinctive virulence determinants evoke
characteristic diarrheagenic symptoms and signs, ExPEC strains are exceedingly heterogeneous and
are known to possess no specific virulence factors or a set of factors, which are obligatory for the
infection of a certain extraintestinal site (e. g. the urinary tract; Caprioli et al., 2005; Clarke et al.,
2003; Johnson et al., 2005b; Johnson et al., 2005d; Nataro, 2005; Welch et al., 2002).
The ExPEC genomes are highly diverse mosaic structures in permanent flux (Dobrindt et al.,
2003). These strains have obtained a significant amount of DNA (predictably up to 25% of the
genomes) through acquisition of foreign DNA from diverse related or non-related donor species by
lateral transfer of mobile genetic elements, including pathogenicity islands (PAIs), plasmids, phages,
transposons, and insertion elements (IS; Dobrindt et al., 2004; Dobrindt and Hacker, 2001; Fischer and
Eisenberg, 1999; Ochman et al., 2005; Pal et al., 2005). The ability of ExPEC strains to cause disease
is mainly derived from this horizontally acquired gene pool; the extragenous DNA facilitates rapid
adaptation of the pathogen to changing conditions and hence the extent of the spectrum of sites that
can be infected (Escobar-Paramo et al., 2004; Hacker and Carniel, 2001; Lerat et al., 2005; Ochman et
al., 2005). However, neither the amount of unique DNA in different ExPEC strains (or UPEC strains)
nor the mechanisms lying behind the observed genomic mobility are known.
Due to this extreme heterogeneity of the UPEC and ExPEC populations in general, the routine
surveillance of ExPEC is exceedingly difficult. In this project, we presented a novel virulence gene
algorithm (VGA) for the estimation of the extraintestinal virulence potential (VP, pathogenicity risk)
of clinically relevant ExPECs and fecal E. coli isolates. The VGA was based on a DNA microarray
specific for the ExPEC phenotype (ExPEC pathoarray). This array contained 77 DNA probes
homologous with known (e.g. adhesion factors, iron accumulation systems, and toxins) and putative
(e.g. genes predictably involved in adhesion, iron uptake, or in metabolic functions) ExPEC virulence
determinants. In total, 25 of DNA probes homologous with known virulence factors and 36 of DNA
probes representing putative extraintestinal virulence determinants were found at significantly higher
frequency in virulent ExPEC isolates than in commensal E. coli strains. We showed that the ExPEC
pathoarray and the VGA could be readily used for the differentiation of highly virulent ExPECs both
from less virulent ExPEC clones and from commensal E. coli strains as well. Implementing the VGA
in a group of unknown ExPECs (n=53) and fecal E. coli isolates (n=37), 83% of strains were correctly
identified as extraintestinal virulent or commensal E. coli. Conversely, 15% of clinical ExPECs and
19% of fecal E. coli strains failed to raster into their respective pathogenic and non-pathogenic groups.
Clinical data and virulence gene profiles of these strains warranted the estimated VPs; UPEC strains
Extraintestinal pathogenic Escherichia coli Summary
2
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki
with atypically low risk-ratios were largely isolated from patients with certain medical history,
including diabetes mellitus or catheterization, or from elderly patients. In addition, fecal E. coli strains
with VPs characteristic for ExPEC were shown to represent the diagnostically important fraction of
resident strains of the gut flora with a high potential of causing extraintestinal infections.
Interestingly, a large fraction of DNA probes associated with the ExPEC phenotype
corresponded to novel DNA sequences without any known function in UTIs and thus represented new
genetic markers for the extraintestinal virulence. These DNA probes included unknown DNA
sequences originating from the genomic subtractions of four clinical ExPEC isolates as well as from
five novel cosmid sequences identified in the UPEC strains HE300 and JS299. The characterized
cosmid sequences (pJS332, pJS448, pJS666, pJS700, and pJS706) revealed complex modular DNA
structures with known and unknown DNA fragments arranged in a puzzle-like manner and integrated
into the common E. coli genomic backbone. Furthermore, cosmid pJS332 of the UPEC strain HE300,
which carried a chromosomal virulence gene cluster (iroBCDEN) encoding the salmochelin
siderophore system, was shown to be part of a transmissible plasmid of Salmonella enterica. Taken
together, the results of this project pointed towards the assumptions that first, (i) homologous
recombination, even within coding genes, contributes to the observed mosaicism of ExPEC genomes
and secondly, (ii) besides en block transfer of large DNA regions (e.g. chromosomal PAIs) also
rearrangements of small DNA modules provide a means of genomic plasticity. The data presented in
this project supplemented previous whole genome sequencing projects of E. coli (Blattner et al., 1997;
Chen et al., 2006; Hayashi et al., 2006; Perna et al., 2001; Welch et al., 2002) and indicated that each
E. coli genome displays a unique assemblage of individual mosaic structures, which enable these
strains to successfully colonize and infect different anatomical sites.
Extraintestinal pathogenic Escherichia coli Introduction
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1. INTRODUCTION
1.1  The clinical background of urinary tract infections (UTIs) caused by
extraintestinal pathogenic Escherichia coli (ExPEC)
Extraintestinal pathogenic Escherichia coli (ExPEC) are a diverse group of strains infecting
extraintestinal locations, including the urinary tract (infected by uropathogenic E. coli [UPEC]), the
bloodstream (infected by sepsis-associated pathogenic E. coli), and the meninges of the neonates
(infected by newborn meningitis-associated E. coli [NMEC]; for recent review see Russo and Johnson,
2003). Urinary tract infections (UTIs) are one of the most frequently acquired bacterial infections
world wide and UPEC, the major subgroup of ExPEC, accounts for around 90% of all ambulatory
UTIs (Foxman and Brown, 2003). Approximately half of the adult women will develop UTI during
their lifetime, one fourth of the women will experience one or more recurrent infections after the first
UTI episode, and about 5% of the women suffer of persistent infections, which significantly interfere
with the daily life. UTIs are responsible for serious morbidity and mortality in the elderly, in young
children, and in immune-compromised patients (Foxman and Brown, 2003; Scholes et al., 2005).
Taken together, UTI episodes greatly burden the public health care systems and the national
economies due to lost hours of work (Russo and Johnson, 2003).
A UTI is clinically defined as the presence of a significant number of pathogenic organisms in
the urine (most often 105 colony forming units/ml urine). The symptom palette extends from
asymptomatic bacteriuria to painful and frequent urination, bloody urine, abdominal pain, nausea,
vomiting, and fever (Stamm, 1982). Symptomatic UTI can be divided into cystitis and pyelonephritis.
Cystitis is an infection of the lower urinary tract and the urinary bladder (Fig. 1). Pyelonephritis is a
life threatening infection affecting the kidneys (Fig. 1). If pyelonephritis is untreated, it often leads to
renal failure and systemic spread of the pathogen into the blood stream (i.e. urosepsis; Fig. 1; Faro and
Fenner, 1998; Mehnert-Kay, 2005).
ExPEC strains are different regarding both their genetic backgrounds and clinical outcomes
from commensal E. coli strains of the normal intestinal flora and from intestinal pathogenic E. coli
strains causing intestinal disease (Dobrindt et al., 2003; Johnson and Russo, 2005). Intestinal
pathogenic E. coli strains possess distinctive virulence factors characteristic of their particular
pathomechanisms and pathogroup (e.g. shiga-toxins of enterohemorrhagic strains [EHEC], intimin of
Figure 1. The urinary tract. The urinary system consists
of the kidneys, the ureter, the bladder, and the urethra.
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enteropathogenic strains [EPEC] and heat-labile and –stable toxins of enterotoxigenic [ETEC] strains).
These determinants are also responsible for the resulting diarrheagenic symptoms (Caprioli et al.,
2005; Clarke et al., 2003; Farthing, 2004). In contrast, ExPEC exhibit a broad range of virulence
factors that enable these strains to colonize mucosal surfaces, avoid or subvert local and systemic host
defense mechanisms, scavenge essential nutrients (e.g. iron), injure and invade the host, and stimulate
a noxious inflammatory response (Bower et al., 2005; Russo and Johnson, 2003). ExPEC strains
colonize effectively the gastrointestinal tract; they constitute a predominant fraction (20%) of fecal E.
coli but do not cause any gastrointestinal disease (Johnson et al., 1998; Murray et al., 2004;
Nowrouzian et al., 2005; Siitonen, 1992). To date, no single virulence factor has been shown to be
unique or restricted to the ExPEC phenotype. Rather, complementary sets of virulence factors
interplay to direct bacteria into infectious pathways that result in disease in a susceptible host (Bower
et al., 2005; Seed and Hultgren, 2005). It is still largely uncertain, whether ExPECs are a group of
pathogens capable of colonizing various anatomical sites, or whether each member is equipped with a
particular set of virulence determinants allowing it to infect distinct body sites by definite
pathomechanisms (e.g. the UPEC pathotype; Johnson and Russo, 2002; Marrs et al., 2005).
Extraintestinal pathogenic Escherichia coli Introduction
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1.2 Bacterial factors contributing to the development and establishment of UTIs
caused by ExPEC
1.2.1  Known fimbrial adhesins
The bladder is a difficult organ to colonize and infect. The intruding pathogen must first withstand the
powerful clearing actions of the urine flow and secondly, the active exfoliation of the epithelial cells
following bacterial attachment (Williams and Schaeffer, 2004). In addition, the pathogen has to avoid
or resist rapid and highly effective inflammatory responses that are evoked locally (Chowdhury et al.,
2004). Up to date, a number of bacterial virulence factors have been characterized (e.g. adhesins, iron
accumulation systems, and toxins), which allow ExPEC to infect distinct body sites (Table 1; Johnson
and Russo, 2005; Marrs et al., 2005).
Despite of the rapidly accumulating epidemiological and experimental data, the ultimate
factor(s) required by UPEC and other ExPEC, as well as the underlying molecular mechanisms
required for initiation and establishment of an extraintestinal infection are still unclear. As virulence
determinants in E. coli are controlled by global regulators (e.g. transcriptional regulators RfaH, DsdC,
DegS, and YbtA), which act in concert under environmental stimuli (e.g. iron deficiency), the causal
relationship between the genotype and the pathotype is often ambiguous (Anisimov et al., 2005; Nagy
et al., 2002; Redford et al., 2003; Roesch et al., 2003). UPEC strains exhibit a number of adhesins,
which allow these pathogens to attach to the urinary tract tissues. Many of the UPEC adhesins have
multiple roles; they are involved in adhesion, invasion, cell cycle control, and modulation of the
inflammatory reactions. Adhesins can be classified as either fimbrial or afimbrial depending upon
whether or not the adhesin is displayed as part of the pilus or the fimbriae. Known fimbrial adhesins
implicated in the urinary tract pathogenesis include P, S, Type I, and Dr fimbriae as well as novel
fimbriae encoded by the auf gene cluster (Bergsten et al., 2004; Buckles et al., 2004; Johnson et al.,
2006; Klumpp et al., 2006; Servin, 2005). Vaccination with purified proteins of P, Type I, and Dr
fimbriae have been shown to protect against infection with UPEC in vivo (Goluszko et al., 2005;
Langermann et al., 2000; Roberts et al., 2004).
In UPEC, Type I fimbriae (encoded by the fim gene cluster) are important virulence factors
(Bahrani-Mougeot et al., 2002; Connell et al., 2000; Hull et al., 2002; Langermann et al., 2000).
Several members of the family of Enterobacteriaceae (Boddicker et al., 2002; Gerlach et al., 1989)
produce these fimbriae. Type I fimbriae are expressed by over 90% of E. coli strains and they are
uniformly distributed among commensal and pathogenic strains (Table 1; Schlager et al., 2003).
FimH, the adhesin subunit of Type I fimbria, is heterogeneous and has different isoforms, which bind
selectively to either monomannose or trimannose residues on a variety of host cell types, mucus, and
abiotic surfaces (Sokurenko et al., 2001; Sokurenko et al., 2004; Vandemaele et al., 2004). All
naturally occurring FimH variants are capable of mediating strong interactions with trimannose, but
the ability to bind a single monomannose residue is the highly variable property of FimH isoforms
(Sokurenko et al., 2004). UPECs express mainly FimH variants with high affinity to monomannose
present only on the receptors of the vaginal, urethral, and bladder epithelium (primarily uroplakins Ia
and Ib; Chapter 1.3.1; Ishikawa et al., 2004). Nevertheless, recent evidence indicates that factors other
than differences in the mannose binding capacity of FimH may explain the distinct FimH adhesion
phenotypes. Bouckaert and colleagues studied a number of FimH variants originating from fecal,
uropathogenic and enterohemorrhagic E. coli and could not find a correlation between the FimH
variation and the affinities or specificities of the variant FimH receptor-binding domains for
oligomannosides. This suggests that varying FimH binding strengths may be more dependent upon the
Extraintestinal pathogenic Escherichia coli Introduction
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receptor (i.e. carbonhydrate expression of the targeted host tissues or the urinary inhibitors), rather
than the adhesin itself (Bouckaert et al., 2006).
P fimbriae (pyelonephritis-associated pilus encoded by the pap gene cluster) are present in more
than 70% of the pyelonephritogenic E. coli (Table 1; Johnson et al., 2005b; Johnson et al. 2005d).
PapG, the adhesin subunit of P fimbriae, selectively recognizes and binds to Gal-α(1-4)Gal –
containing glycosphingolipids present only on the renal tissue epithelium (Dodson et al., 2001;
Ishikawa et al., 2004; Larsson et al., 2003). PapG has three allelic variants (PapGI, PapGII, and
PapGIII), with class II being the most prevalent allele among ExPEC (34%; Table 1; Bingen-Bidois et
al., 2002; Johnson et al., 1999).
Occurrence of the closely related S (the sfa gene cluster) and F1C fimbriae (the foc gene cluster)
is associated to E. coli infecting the urinary tract and the meninges (Table 1; Johnson et al., 2005b;
Johnson et al. 2005d; Korczak et al., 2005). The S and F1C fimbrial adhesins (SfaS and FocA,
respectively) recognize and attach to the α-sialic acid residues present on diverse epithelial surfaces
(Hacker et al., 1993; Morschhauser et al., 1993; Ott et al., 1988). These fimbriae are encoded by
around 35% of ExPEC strains (Johnson et al., 2005b; Johnson et al. 2005d; Korczak et al., 2005).
Commonly encountered virulence factors in UPEC are Dr fimbriae (encoded by the dra gene
cluster; Table 1; Goluszko et al., 2005). Dr fimbriae belong to the family of Afa/Dr adhesins (the
hallmark of diffuse adherent E. coli), which bind to the complement regulatory protein decay
accelerating factor expressed on the epithelial surfaces (Fang et al., 2004; Hasan et al., 2002; Nowicki
et al., 2001). The afimbrial members of the Afa/Dr family of adhesins are referred to more closely in
the following Chapter 1.2.2.
The fimbrial “newcomers” (Auf fimbriae) of ExPEC are encoded by the aufABCDEFG gene
cluster, which was recently described in the archetypal UPEC strain CFT073 by Buckles and co-
workers (Buckles et al., 2004). Auf fimbriae are significantly associated with UPEC when compared
to commensal E. coli belonging to the intestinal normal flora (Table 1). AufA, the major structural unit
of Auf fimbriae, is expressed in vivo in the murine urinary tract (Buckles et al., 2004). So far, no
hemagglutination or cellular adherence properties have been described for Auf fimbriae and hence the
role of these fimbriae in the ExPEC pathogenesis is unclear.
During an UTI, the ExPEC population alternates between fimbriated and non-fimbriated states.
Most fimbrial gene clusters are phase-variable, and the ability to control the ON/OFF- switch of
fimbrial biogenesis strongly influences the virulence of ExPEC (Gunther IV et al., 2002; Hernday et
al., 2004; Lee et al., 2004; Schlager et al., 2003). Recent studies show that spatially separated fimbrial
gene clusters "communicate" with each other; the regulatory genes of one cluster influence the
expression of other fimbriae (Pourbakhsh et al., 1997; Roesch et al., 2003; Snyder et al., 2004; Snyder
et al., 2005). Nonetheless, neither the transient fimbriation status in an infecting population, nor the
environmental stimuli required for the full expression of fimbriae during an infection are known. Even
if the roles of different fimbriae in the ExPEC pathogenesis are largely unresolved, there is strong
evidence suggesting that the ExPEC fimbriae are involved in the various stages of UTI; they promote
bacterial adhesion and invasion as well as cytokine production, inflammation, and apoptosis (i.e. the
programmed cell death) in the host's phagocytic and epithelial cells (Mulvey et al., 2000; Mysorekar et
al., 2002; Schilling et al., 2003; Svanborg et al., 2001).
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1.2.2 Known afimbrial adhesins
The relation between bacterial adherence and urovirulence become evident in the 1970s (Duguid et al.,
1955; Eden et al., 1976; Eden and Hansson, 1978). The first afimbrial adhesins in UPEC were
described in the 1980s and referred to as "X adhesins" (Vaisanen et al., 1981). To date, a number of
afimbrial virulence traits have been characterized, which allow UPEC adhere to and, in some cases,
invade tissues of the urinary tract (e.g. the Afa/Dr adhesins; Doye et al., 2002; Guignot et al., 2001).
The E. coli strains bearing AfaDE adhesins (the afa gene clusters) of the Afa/Dr adhesin family
are associated with both urinary tract and intestinal infections (Table 1; Servin, 2005). The afimbrial
AfaDE adhesin is composed of two proteins with different roles in the bacterium-cell interactions, i.e.
the adhesin subunit AfaE and the invasin subunit AfaD (Anderson et al., 2004; Garcia et al., 1996).
The adhesive subunit AfaE is highly variable; the 13 known subtypes of AfaE differ in amino acid
(AA) sequence, receptor repertoire, and host specificity (Nowicki et al., 2001; Servin, 2005). The
fimbrial and afimbrial Afa/Dr adhesins of UPEC (e.g. Dr fimbriae [Chapter 1.2.1.] and AfaE subtypes
-1, 3, and -8) primarily elicit the recruitment of decay accelerating factor (Berger et al., 2004; Garcia
et al., 2000; Le Bouguenec et al., 2001). However, internalization promoted by the AfaD invasin is
mediated through interaction with the epithelial integrin receptors (Guignot et al., 2001; Plancon et al.,
2003).
The putative adhesin Hek (encoded by the hek gene; hemagglutinin from E. coli K1) was
originally identified in a chromosomal gene island termed the Pathogenicity Island (PAI) II of the
archetypal UPEC strain 536 (Dobrindt et al., 2002). The protein sequence of Hek is highly similar
(90% sequence identity) to heat-resistant agglutinin 1 (Hra) of EPEC (Lutwyche et al., 1994). The hek
homologue hra is significantly associated with UPEC when compared to E. coli of fecal origin (Table
1; Srinivasan et al., 2003). While the functional role of Hek in UTI is unknown, Hra in intestinal
pathogenic E. coli is a mannose-resistant hemagglutinin, which promotes agglutination of human
erythrocytes and colonic cells (Fleckenstein et al., 2000).
Uropathogenic variant of the outer membrane protein Iha (encoded by the iha gene; IrgA-
homologue adhesin) was originally identified in the UPEC strain CFT073 (Redford et al., 2003). This
protein is homologous with the IrgA (iron-regulated gene A) -like adhesins of EHEC and Vibrio
cholerae (Goldberg et al., 1992; Tarr et al., 2000). In V. cholerae IrgA has a dual function; it serves
both as an adhesin and as a receptor for the siderophore enterobactin (Mey et al., 2002). Recently,
Johnson and colleagues showed that iha is significantly associated with the ExPEC phenotype (Table
1; Johnson et al., 2005a; Kanamaru et al., 2003). In addition, Iha conferred upon a non-adherent E.
coli the ability to adhere to uroepithelial cells in vitro and in vivo (Johnson et al., 2005a). However,
whether Iha contributes to the adherence directly or indirectly in concert with other bacterial
components is not known.
1.2.3  Iron accumulation systems
Iron is essential for the growth of E. coli. Even though iron is abundant in nature, most of it forms
insoluble hydroxide-complexes under oxygen and at neutral pH. In mammalian organisms, the
concentration of free iron (Fe3+) is extremely low (10-18 M); the remaining iron concentration is further
reduced by binding of iron to the host's iron-chelating proteins, like albumin, heme, hemoglobin,
ferritin, transferrin, and lactoferrin (Bullen et al., 2005). Therefore, pathogenic E. coli have developed
several effective iron uptake systems and the ability of iron accumulation significantly contributes to
the virulence of these strains (Braun, 2003; Bullen et al., 2005).
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Lankford et al. introduced the term "siderophore" in 1973 (from the Greek "iron bearer") - 20
years after discovery of the first siderophore ferrichrome - to describe low molecular weight ferric iron
chelators synthesized by bacteria, yeasts, fungi, and plants (Haas, 2003; Lankford, 2005; Neilands,
1981; Staiger, 2002). Most of the E. coli strains synthesize siderophores and their receptors in
response to iron stress. In addition to their own siderophores, these strains are also able to utilize
several different siderophores synthesized by other microorganisms (Braun, 2003). Additionally, a
number of iron uptake systems of E. coli are siderophore independent (e.g. hemin receptors). These
receptors act in concert with cytolytic hemolysins (see Chapter 1.2.4.), and thus account for the uptake
of iron bound to the intracellular heme and hemoglobin (Andrews et al., 2003; Braun, 2003).
ExPEC strains possess several sophisticated siderophore systems; 11 functional and putative
iron uptake systems have been identified in the archetypal UPEC strain CFT073 (Welch et al., 2002).
The distinct siderophores ensure a constant supply of iron in different iron-deficient environments (e.g.
due to varying water solubility; Konopka and Neilands, 1984). Several siderophores favored by
ExPEC (e.g. aerobactin, yersiniabactin, and salmochelin) are largely unaffected by the siderophore-
binding serum proteins, such as albumin (Bister et al., 2004; Konopka and Neilands, 1984). The
known siderophore and siderophore receptor systems in ExPEC include enterobactin, aerobactin,
yersiniabactin, and salmochelin uptake systems (Hantke et al., 2003; Pettis and McIntosh, 1987;
Schubert et al., 2004; Torres et al., 2001). Ferri-siderophore complexes are internalized through a
complex network of proteins, composed of the siderophore specific receptors and of proteins involved
in the energy transfer and trans-membrane passage of these complexes (e.g. TonB; Braun, 2003). The
expression of siderophore systems is up-regulated during bacterial growth in the urinary tract, which
indicates the importance of effective iron assimilation for the UPEC virulence (Snyder et al., 2004).
The siderophore system specific for the hydroxamate siderophore aerobactin significantly
contributes to the virulence of ExPEC (Torres et al., 2001). The aerobactin biosynthetic gene cluster
(iuc) and the ferri-aerobactin receptor (iutA) were first identified in enteroinvasive E. coli as part of the
virulence plasmid pColV (Williams, 1979). The iuc-iutA system is distributed throughout intestinal
and extraintestinal pathogenic strains of E. coli, Shigella spp. Salmonella sp., Klebsiella sp. and Vibrio
sp., and its expression influences the virulence of these strains (Table 1; Demir and Kaleli, 2004;
Kingsley et al., 1995; Koczura and Kaznowski, 2003; Moon et al., 2004; Purdy and Payne, 2001).
The catecholate siderophore yersiniabactin was first described in Yersinia pestis, the infectious
agent of bubonic plague (Fetherston and Perry, 1994). In most of the characterized ExPEC strains, the
yersiniabactin biosynthetic gene cluster (irp) and the yersiniabactin receptor FyuA are encoded by a
conserved chromosomal gene island denoted as the High Pathogenicity Island (Carniel et al., 1996).
To date, this island has also been identified in several other pathogenic members of the family
Enterobacteriaceae (Schubert et al., 2004). The irp-fyuA gene cluster is associated with the ExPEC
phenotype and its expression contributes to the virulence of these strains in vivo (Table 1; Koczura and
Kaznowski, 2003; Schubert et al., 1998; Schubert et al., 2002).
The siderophore receptor IroN was first described in S. enterica and later in the archetypal
ExPEC strain CP9 (Baumler et al., 1998; Russo et al., 1999). The receptor IroN and the enterochelin
glycosylase IroB, which is required for the synthesis of the novel siderophore salmochelin from the
siderophore enterobactin, are encoded by the iro gene cluster (Hantke et al., 2003). IroN mediates the
uptake of salmochelin and other catecholate siderophores (e.g. enterobactin and dihydrobenzoic acid)
and contributes significantly to the virulence of UPEC and NMEC in the infection models of
ascending UTI and neonatal meningitis, respectively (Table 1; Hantke et al., 2003; Negre et al., 2004;
Russo et al., 2002).
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The siderophore enterobactin (encoded by the ent gene cluster) and its receptor FepA are
produced by pathogenic and non-pathogenic E. coli as well as by a number of other Gram negative
and positive bacteria (Table 1; O'Brien and Gibson, 1970; Raymond et al., 2003). However, although
enterobactin is an effective iron chelator, it is bound strongly by the serum albumin and hence
inactivated in the human serum (Konopka and Neilands, 1984). As enterobactin and its receptor are
produced equally by pathogenic and non-pathogenic E. coli strains, their role in UTIs is probably only
diminutive (Demir and Kaleli, 2004).
A number of gene clusters with putative function in the iron metabolism have been described in
ExPEC. For example, the prrA-modD-yc73-fepC gene cluster (TonB-dependent outer membrane
receptor; molybdenum transport protein; protein similar to Haemophilus influenzae protein yc73;
ferric enterobactin transport ATP-binding protein) was originally identified as part of a PAI of the
UPEC strain CFT073 and it is predominantly found in clinical ExPEC isolates (Table 1; Guyer et al.,
1998). The genes encoding outer membrane proteins ChuA (chuA; E. coli heme-utilization) and IreA
(ireA; iron-responsive element) are found in several ExPEC strains (Table 1; Russo et al., 2001; Torres
and Payne, 1997). By the virtue of sequence homology, these proteins are involved in the iron uptake
in TonB-dependent manner (Guyer et al., 1998). However, their function and impact in the ExPEC
virulence must be elucidated.
1.2.4  Toxins and proteases
Several bacterial toxins (endo- and exotoxins), proteases, and other effector proteins have established
or putative functions in the ExPEC virulence. Their various biological roles and activities include cell
adhesion, iron accumulation, and cell invasion through cell lysis and disruption of the mucin layer and
the epithelium, as well as modulation and induction of the cell cycle, inflammatory reactions, and
apoptosis (Goni and Ostolaza, 1998; Nougayrede et al., 2005).
The E. coli α-hemolysin (encoded by the hlyA gene) was identified as an urovirulence factor in
the early 1920s (Table 1; Cooke and Ewins, 1975; Dudgeon, 1921). The hly operon encodes the
secreted cytolytic toxin HlyA and accessory proteins required for its modification and secretion (Cross
et al., 1990; Welch and Pellett, 1988). The UPEC HylA has a dual physiological function; at high
concentrations, this toxin is cytolytic due to its pore-forming activity in the plasma membrane (Goni
and Ostolaza, 1998; Soloaga et al., 1999). At sublytical concentrations, HlyA interacts with the cell
membrane and induces intracellular Ca2+-oscillations. In this way, it interferes with the Ca2+ -
dependent signaling pathways involved in the modulation of inflammatory responses of the target cells
(Oxhamre et al., 2005; Soderblom et al., 2002; Uhlen et al., 2000).
Cytotoxic necrotizing factors 1 and 2 (encoded by cnf genes; CNFs) are lethal for a wide
variety of eukaryotic cells and produced by intestinal and extraintestinal pathogenic E. coli (Table 1;
Hoffmann and Schmidt, 2004; Landraud et al., 2004; Mills et al., 2000). The CNF toxins are
composed of two domains: the cell-binding domain and the catalytic domain (Lemichez et al., 1997).
These toxins activate the host's Rho GTPases and therefore influence the regulatory pathways of the
actin cytoskeleton, transcription, cell transformation, cell proliferation, and apoptosis (Chung et al.,
2003; Falzano et al., 2003; Mills et al., 2000; Oswald et al., 1994; Peres et al., 1997). Consequently,
the phagocytic activity of the epithelial cells increases, which enables the crossing of the epithelial
barrier by the CNF-producing E. coli (Fiorentini et al., 2001; Landraud et al., 2004). In addition,
similarly to several other virulence factors described for UPEC (see chapters 1.2.1. and 1.2.2.), also
CNFs modulate and impair immune responses by influencing the secretion of inflammatory mediators
(Fiorentini et al., 2003; Malorni et al., 2003; Munro et al., 2004).
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UPEC has four outer membrane serine proteases (Sat, PicU, Hbp, and OmpT) with different
substrate specificities and protease functions (Table 1; Guyer et al., 2002; Kukkonen and Korhonen,
2004; Otto et al., 1998; Parham et al., 2004). Sat (sat) is a serine auto-transporter toxin, which
displays cytopathic activities on the kidney and bladder epithelium in vitro and in vivo (Guyer et al.,
2002). Hemoglobin-protease Hbp (hbp) is a homologue of the Tsh hemagglutinin of avian pathogenic
E. coli (APEC). Hbp and Tsh are heme-binding proteins with serine protease activity targeted at
hemoglobin (Tivendale et al., 2004). The UPEC PicU (picU) is homologous with Pic (protein
involved in intestinal colonization) of Shigella spp. and enteroaggregative E. coli. Pic proteases disrupt
mucosal barriers by degrading mucosal pepsin, spectrin, and mucin (Bellini et al., 2005; Henderson et
al., 1999; Parham et al., 2004). OmpT (ompT), the fourth outer membrane endopeptidase of ExPEC, is
structurally similar to plasminogen activator Pla of Y. pestis and degrades antimicrobial peptides
secreted by the epithelial cells and macrophages (Grodberg et al., 1988; Kukkonen and Korhonen,
2004).
Cytolethal distending toxins (encoded by cdt genes; CDTs) are bacterial effector molecules
able to manipulate the eukaryotic cell cycle (Nougayrede et al., 2005). These toxins consist of the
catalytic domain (CdtB) and carrier subunits required for the receptor recognition and delivery of the
catalytical domain into nucleus of the target cells (Lara-Tejero and Galan, 2001). CdtB causes
chromatin damage, which activates the cellular DNA damage signaling pathways (Frisan et al., 2002).
The most commonly reported response to the CDT intoxication is an irreversible blockade of the cell
cycle, but the effects of CDTs vary depending on the cell type (e.g. necrosis versus apoptosis;
Bielaszewska et al., 2005; Yamamoto et al., 2004). Although a number of ExPEC strains are positive
for CDTs, their function in the pathogenesis of these strains is not known (Table 1).
Microcins (mch) and colicins (cva) are antimicrobial peptides secreted by various members of
the Enterobacteriaceae family (Table 1; Gillor et al., 2004; Patzer et al., 2003). They are produced
under conditions of nutrient depletion and are active against phylogenetically related microbial strains.
Microcins and colicins are considered to play important roles in the microbial competitions within the
infecting populations and the intestinal flora (Azpiroz et al., 2001; Snyder et al., 2004).
Uropathogen specific protein (usp) was first identified as part of a novel PAI of the UPEC
strain Z42 by Kurazono and colleagues in Japan in 1999 (Kurazono et al., 2000; Yamamoto et al.,
2001). Usp is similar to the Pseudomonas aeruginosa toxin pyocin and the E. coli colicins. The usp
gene is significantly associated with ExPEC and its expression increases the infectivity of non-
pathogenic E. coli laboratory strains in the mouse model of ascending pyelonephritis (Table 1;
Yamamoto et al., 2001). However, the biological function of Usp in UTIs is still unknown.
The gram-negative endotoxin lipopolysaccharide (LPS) is the main bacterial factor in the
development of endotoxemia, the pathogen-induced systemic immune response leading to the lethal
shock-condition of the host (Zimecki et al., 2004). In the ascending UTI, the O-polysaccharide moiety
of the UPEC LPS has an important regulatory function (Fischer et al., 2006; Svanborg et al., 2001).
LPS signals through Toll-like receptor -4 (TLR4) of the urothelial and inflammatory cells and hence
induces production of pro-inflammatory mediators (e.g. cytokines and chemokines) and cellular nitric
oxide synthases (Austin et al., 2003; Backhed et al., 2003; Cross et al., 1995). The LPS-induced
systemic inflammation breaks the inertia of mucosal barrier and allows UPEC to gain the access into
the underlying tissues. On the mucosal surfaces of the urinary tract, the LPS-dependent activation of
host's TLR4-signaling is dependent of the adhesins of Type I or P fimbriae (Chapter 1.2.1.; Blomgran
et al., 2004; Fischer et al., 2006; Hedlund et al., 2001).
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1.2.5  Surface coatings
Bacterial surface coatings, i.e. capsular polysaccharides (K-antigens), LPS, and O-polysaccharide
moieties of LPS (O-antigens) have been implicated as possible virulence determinants in
extraintestinal infections (Kusecek et al., 1984; Russo et al., 1996). There are 176 different O-
serogroups and more than 80 K-antigens in E. coli. In addition, many E. coli strains are able to
synthesize colonic acid, the main component of the polysaccharide coatings of biofilms (Reisner et al.,
2003). LPS and its impact in UTIs were described in more detail in chapter 1.2.4.
E. coli produces four types of capsular polysaccharides (groups 1 to 4), each of which
comprises of a large number of distinct types (Keenleyside et al., 1993). Most ExPEC strains have
capsules and certain capsule types (e.g. K1, K5, K10, and K54) have been shown to contribute to the
pathogenesis of these strains (Horwitz and Silverstein, 1980; Pluschke et al., 1983; Schneider et al.,
2004; Suerbaum et al., 1994; Whitfield and Roberts, 1999). Similarly, UPEC strains are more likely to
belong to the O-antigen serotypes O1, O2, O4, O6, O16, O18, O22, O25, and O75 (Johnson et al.,
1994; Korhonen et al., 1985; Kusecek et al., 1984; Russo et al., 1996). The genes responsible for the
capsular polysaccharide and LPS synthesis in the UPEC strain CFT073 are highly expressed during
experimental UTI, which indicates the importance of surface coatings in vivo (Snyder et al., 2004).
However, whether certain O-polysaccharide or capsular antigens contribute to the ascending UTI is
not clear. Some studies implicate that bacterial coatings may account for the increased serum
resistance and thus impede the clearance of ExPEC by phagocytosis (Horwitz and Silverstein, 1980;
Leying et al., 1990; Pluschke et al., 1983; Rizvi and Kumar, 2003; Suerbaum et al., 1994).
1.2.6  Flagellar motility
At present, 53 flagellar antigens (H-antigens) are described for E. coli (Wang et al., 2003). The
virulence of diarrheagenic E. coli has been shown to be dependent of the expression of functional
flagella (Best et al., 2005; Nougayrede et al., 2003; Sircili et al., 2004). Flagella are supposed to be
essential adhesive organs in establishing E. coli extra- and intracellular biofilms (Justice et al., 2004;
Reisner et al., 2003; Tenorio et al., 2003; Wright et al., 2005). However, the impact of flagellar
motility in the colonization of the urinary tract is still subtle. Flagellar and chemotaxis genes have
shown to be down regulated during an experimental UTI (Snyder et al., 2004). But while the non-
motile UPEC can advance through the stages of UTI in both the bladder and the kidney, the functional
flagella have shown to confer a fitness advantage in persisting throughout the urinary tract and may
therefore enhance the UPEC pathogenesis (Anderson et al., 2004; Justice et al., 2004; Lane et al.,
2005; Snyder et al., 2004; Wright et al., 2005).
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Table 1. Prevalence of genes encoding known ExPEC virulence factors among ExPECs and commensal E. coli isolates.
Prevalence (%)aGene
ExPEC Commensal
E. coli
Reference
Fimbrial adhesins
auf 60 31 Buckles et al., 2004
fimH 67-100 58-92 Johnson et al., 2005b;  Johnson et al. 2005d; Moreno et al., 2005
papC 60 37 Johnson et al., 2005b; Johnson et al. 2005d
papGI 0-2 0 Bingen-Bidois et al., 2002; Johnson et al., 2005
papGII 40-62 3-25 (45b) Johnson et al., 2005; Moreno et al., 2005; Nowrouzian et al., 2003
papGIII 5-31 3 (34b) Bingen-Bidois et al., 2002; Johnson et al., 2005b; Johnson et al. 2005d; Nowrouzian et al., 2003
sfa/foc 14-24 (59c) 0 (26b) Bingen-Bidois et al., 2002; Duriez et al., 2001; Johnson and Stell, 2000; Johnson et al., 2005b; Johnson
et al. 2005d; Nowrouzian et al., 2003; Watt et al., 2003
Afimbrial adhesins
afa/dra 3-14 (39c) 0-5 Johnson et al., 2005b; Johnson et al. 2005d; Johnson and Stell, 2000; Moreno et al., 2005; Watt et al.,
2003
hra 43-66 28 Srinivasan et al., 2003
iha 33-74 12-25 Kanamaru et al., 2003; Moreno et al., 2005; Johnson et al., 2005b; Johnson et al. 2005d
Iron accumulation systems
aer 50-80 16-50 Bingen-Bidois et al., 2002; Duriez et al., 2001; Johnson et al., 2005b; Johnson et al. 2005d; Korczak et
al., 2005; Moreno et al., 2005; Nowrouzian et al., 2003; Ruiz et al., 2002
chuA 70-95 30 Hoffmann et al., 2001; Korczak et al., 2005
ent 44-86 63-90 Demir and Kaleli, 2004; Koczura and Kaznowski, 2003b
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fep 90 22 Guyer et al., 1998
ireA 26 0 Russo et al., 2001
iro 51-78 7-44 Johnson et al., 2005b; Johnson et al. 2005d; Kanamaru et al., 2003
mod 93 33 Guyer et al., 1998
prr 87 26 Guyer et al., 1998
y73 90 19 Guyer et al., 1998
irp 81-92 58-67 Bingen-Bidois et al., 2002; Johnson et al., 2005b; Johnson et al. 2005d;  Johnson and Stell, 2000 ;
Moreno et al., 2005
Toxins and proteases
cdtB 6-9 5 Johnson and Stell, 2000; Johnson et al., 2005b; Johnson et al. 2005d; Moreno et al., 2005
cnf 15–61 0-10 Duriez et al., 2001; Korczak et al., 2005; Johnson et al., 2005b; Johnson et al. 2005d; Johnson and
Stell, 2000
hbp 63 33 Heimer et al., 2004
mch 36 3 Grozdanov et al., 2004
hly 21-79 4-20 (23b) Duriez et al., 2001; Johnson et al., 2005b; Johnson et al. 2005d; Johnson and Stell, 2000; Moreno et al.,
2005; Nowrouzian et al., 2003
ompT 83-94 51-68 Kanamaru et al., 2003
pic 31 7 Heimer et al., 2004
sat 30-55 22 Guyer et al., 2000; Ruiz et al., 2002
usp 85 24 Kanamaru et al., 2003
a The estimated prevalence of virulence factors varies between diverse studies and is strongly dependent upon the strain collection used
b Healthy infants of 3 to 12 months of age
c Pregnant women
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1.3  Impact of host factors contributing to the development and recurrence of UTIs
caused by ExPEC
Development and severity of UTIs are influenced not only by the invading pathogen but also by the
host. A variety of host factors, such as age, gender, pregnancy, or immunological status may
predispose towards UTI and allow less virulent pathogens to cause the disease (Gordon et al., 2005).
Structural disorders of the urinary tract or the presence of foreign bodies (e.g. the urinary
catheter) impair the urine flux and are common risk factors for UTI (Honkinen et al., 1999; Nicolle,
2005). In addition, metabolic disorders and autoimmunity diseases (e.g. diabetes mellitus and lupus
erythematosus) have been shown to contribute first, to the enhanced colonization of the otherwise
sterile urinary tract by pathogenic bacteria and secondly, to the impaired clearance of an infection by
the host (Hidalgo-Tenorio et al., 2004; Hoepelman et al., 2003).
UTIs caused by UPEC are the most common bacterial infections during pregnancy. These
infections are often accompanied by serious complications, such as preterm labor or early onset of
neonatal sepsis, which may lead to significant morbidity and mortality in both the fetus and the mother
(Jones et al., 2004; Le et al., 2004). There are several studies documenting causal relationship between
sex practices and elevated risk of UTIs; sexual activity (e.g. intercourse frequency or the use of
spermicide-based contraception) is associated with an increased risk of UTIs and their recurrences
(Foxman et al., 2002; Karkkainen et al., 2000; Kontiokari et al., 2003). These activities partly explain
the observed relation of UTIs to the age, recurrent UTIs being most common in women of 25 to 29
years of age. The second UTI risk group is comprised of women over 55 years of age (Foxman and
Brown, 2003; Hu et al., 2004). In this age group, the frequent and recurrent UTIs are explained with
an increasing urinary incontinence, a decreased estrogen level, and an altered ABO-blood group
secretor status (Hu et al., 2004; Jackson et al., 2004; Rozenberg et al., 2004). Men are relatively rarely
affected by UTI and prostatis; approximately 14% of men have experienced one or more UTIs
(Griebling, 2004). UTI, urosepsis, and UTI-associated meningitis are the major causes of bacterial
infections in infants younger than 90 days (Bachur and Caputo; 1995). Male infants are above average
affected by UTIs and UTI-associated sepsis, and the main causes of infant urosepsis are anatomical or
functional abnormalities of the urinary tract (Bachur and Caputo, 1995; Ginsburg an McCracken,
1985; Honkinen et al., 2000).
Finally, domestic animals can serve as reservoirs for ExPEC and may increase the risk to
acquire UTI (Chen et al., 2003; Murray et al., 2004). Dietary factors, such as frequent consumption of
fresh berry juices and fermented milk products, use of probiotic micro-organisms, and breast feeding
of neonates, have been shown to protect against UTI (Hoesl and Altwein, 2005; Kontiokari et al.,
2003; Marild et al., 2004; Martin-Sosa et al., 2002). However, the causal relationships between the
host's immunological status or life style and UTIs are not clear.
1.3.1  Histology of the urinary tract
Urothelium, the epithelium lining the urinary tract is composed of three cell types: undifferentiated
basal cells, intermediate cells, and superficial facet cells (Fig. 2). It is covered with microvilli and
mucus. Superficial cell layers are connected by tight junctions, which a physical barrier to the
infection. These cells express four types of integral membrane proteins (i.e. uroplakins Ia, Ib, II and
III), which are recognized by UPEC. Uroplakins Ia and II are strictly specific for the urothelium
(Olsburgh et al., 2003). The turnover rate of the normal bladder epithelium is extremely slow and its
regeneration in humans is estimated to take 6 to 12 months (Southgate et al., 1999).
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1.3.2 Host response to UTIs
UPEC interact with the host at two levels: at the mucous surfaces lining the urinary tract and at the
tissues of the kidney and the bladder (Mulvey, 2002). In the first phase of UTI, invading pathogens
bind to receptors (e.g. uroplakins; Chapter 1.3.1.) on the mucosal surfaces coating the urothelium (Fig.
3). During the acute phase of UTI, widening of the tight junctions and extensive exfoliation of the
urothelial cells take place. This active exfoliation of the infected cells is initiated by the host and
serves to eliminate the bulk of adherent bacteria, but it also detrimentally exposes the underlying
undifferentiated basal cells (Fig. 3; Mysorekar et al., 2002). The loss of epithelial integrity is
complemented by a rapid renewal of the urothelium and by the accumulation of epithelial proteins
(Mysorekar et al., 2002). In addition, receptors for the leukocyte integrins and circulating leukocytes
are highly expressed on the infected urothelium (Mysorekar et al., 2002). These leukocyte adhesion
molecules play a key role in the inflammatory processes; they activate and assist in the epithelial
transmigration of circulating leukocytes (e.g. polymorphonuclear neutrophils and macrophages), the
key effectors against UPEC (Fig. 3; Detmers et al., 1990).
The host's first line of defense against UPEC (i.e. the. innate immunity) involves a complex
interplay of unspecific antimicrobial proteins, including the urinary Tamm-Horsfall protein, defensins,
and complement proteins, as well as cytokines and inflammatory cells (Fig. 3; Nitschke et al., 2002;
Saemann et al., 2005; Schilling et al., 2003). The main cytokines secreted during UTI include
transforming growth factor β, tumor necrosis factors α and β, interferon γ, and interleukins 6 and 8
(IL; Fig. 3). These mediators are produced by the bladder and renal epithelial cells and are present in
highly elevated levels in the urine of patients during the acute phase of UTI (Farmaki et al., 2005;
Funfstuck et al., 2001; Schilling et al., 2003). In the response to cytokines and leukocyte adhesion
molecules expressed by the infected urothelium, phagocytic cells migrate through capillary cell walls
(Fig. 3; Gbadegesin et al., 2002; Godaly et al., 2001). Once at the site of infection, phagocytes
recognize opsonised bacteria through specific receptors (Durand et al., 2001; Nishimura et al., 2001).
Cytoplasmic granules within these cells contain a number of antimicrobial products and reactive
oxygen intermediates (Fang, 2004; Wiedow and Meyer-Hoffert, 2005); following phagocytosis, these
Figure 2. Haematoxylin and eosin stained mouse
urothelium
SFC = superficial facet cells,
IC = intermediate cells
Figure kindly provided by K. Hildinger
(Max von Pettenkofer-Insitut).
SFC
IC
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granules fuse with the phagosomes leading to effective killing of indigested bacteria (Chowdhury et
al., 2004).
The innate and adaptive immune systems collaborate to provide protection against invading
pathogens. A couple of days after the initial infection phagocytic cells are accompanied by the
antibody producing and cytotoxic immune cells. The UPEC specific antibodies elicited in response to
UTI are primarily immunoglobulins A (IgA), IgM, and IgG; they are commonly directed against LPS,
outer membrane proteins, and fimbriae (e.g. Type I and P fimbriae; Gibb and Edmond, 1992; Kantele
et al., 2003; Kawahara et al., 1994; Nicolle et al., 1989; Salit et al., 1988). The secretory-IgA plays a
pivot role in the immunological defense of the urinary tract by preventing the initial bacterial
adherence to the urothelium (Deo and Vaidya, 2004).
Cells of the human immune system as well as the bladder and renal epithelial cells, express 10
(11 in mice) distinct types of TLRs on their surfaces. These receptors are involved in the recognition
of conserved molecular patterns unique for microbes, such as the bacterial LPS, lipoproteins, fimbriae,
and flagellin as well as viral and bacterial RNA and DNA (Finberg et al., 2004; Takeda and Akira,
2004). During UTI, the LPS-specific signaling through TLR4 (and TLR11 in mice) is necessary for
host's cytokine production, activation of the immune-cells, and the tissue integrity control (Takeda and
Akira, 2005; Zhang et al., 2005).
Intact function of the urothelium and innate immune-defenses are essential for the resistence
and clearance of UTIs caused by UPEC; deficiencies in the urothelial integrity, phagocyte activation
and function, secretion of antimicrobial proteins, cytokines, and antibodies have been described in the
patient groups susceptible to UTIs (Chapter 1.3.; Chowdhury et al., 2004; Williams and Schaeffer,
2004). The inability of the host to induce an appropriate immune response may result in recurrent or
chronic infections and provoke additional pathological conditions, including autoimmune diseases and
renal dysfunction (Stojanovic et al., 2004).
Untreated pyelonephritis is a life threatening condition associated with the scarring of the
renal tissue, loss of glomerular function, and an eventual loss of renal function (Jahnukainen et al.,
2005). Although the mechanisms responsible for the renal scars are obscure, there is strong evidence
that the tissue damage is caused by uncontrolled inflammation resulting from an unbalanced cytokine
or TLR control rather than by any direct bacterial influence (Chowdhury et al., 2004; Jahnukainen et
al., 2005).
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Figure 3. Loss of mucosal integrity during the acute phase of UTI.  During the acute phase of UTI, UPEC
disrupts the mucosal integrity by secreting cytotoxins, inducing apoptosis, and foremost, by
triggering a strong inflammatory reaction in the host's urothelium. Host responses to the bacterial
invasion include active exfoliation of the infected cells and secretion of soluble bacterial inhibitors
(e.g. Tamm-Horsfall protein and secretory-IgA) and inflammatory cytokines (e.g. IL-6 and IL-8)
as well as expression of receptors for the circulating leukocytes. In the response to cytokines and
leukocyte adhesion molecules expressed by the infected urothelium, phagocytic cells (e.g.
polymorphonuclear neutrophils [PMN] and macrophages) migrate through capillary cell walls into
the site of infection. Once at the site of infection, PMNs and macrophages secrete cytokines and
reactive oxygen intermediates, which further enhance the inflammation.
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1.4  Genomic structure of ExPEC
1.4.1 Clonal origin
Phylogenetic analyses have shown that the natural populations of E. coli are basically clonal and that
E. coli strains fall into four main phylogenetic groups (PGs; A, B1, B2, and D; Johnson and Russo,
2005; Ochman and Selander, 1984; Pupo et al., 1997). ExPEC strains belong mainly to the PG B2 and
to a lesser extent to the group D, whereas most commensal E. coli isolates belong to the PGs A and B1
(Clermont et al., 2000; Clermont et al., 2001; Picard et al., 1999). Recent studies indicate that most of
ExPEC strains have evolved from an ancestral strain by a stepwise accumulation of virulence factors
through horizontal gene transfer (Bidet et al., 2005; Dobrindt and Hacker, 2001). The specific genetic
background (e.g. the PG B2) may be required for the acquisition and expression of these virulence
factors (Bidet et al., 2005; Dobrindt et al., 2002; Escobar-Paramo et al., 2004; Le Gall et al., 2005;
Picard et al., 1999). However, the sole association of an E. coli strain with a certain PG does not
necessarily render the strain pathogenic or non-pathogenic as the adaptation of a strain to a host also
contributes significantly in determining its virulence (Duriez et al., 2001; Souza et al., 1999).
1.4.2  Genomic variation
During the last decade, high-throughput techniques have been developed that allow the sequencing of
bacterial chromosomes in a short time. To date, about 140 bacterial chromosomes have been
completely sequenced and the genome sequences are available at the databases of the National Center
for Biotechnological Information (NCBI; http://www.ncbi.nlm.nih.gov) and the European
Bioinformatics Institute (EBI; http://ebi.ac.uk). From the numerous sequence data available in these
databases, it has become obvious that E. coli genomes are highly diverse mosaic structures in
permanent flux. Comparison of the genome sequences of three archetypal E. coli strains, namely the
EHEC strain EDL933 (5.5 mega base pairs [Mb]; NC_002655), the UPEC strain CFT073 (5.2 Mb;
NC_004431), and the commensal E. coli strain MG1655 (4.6 Mb; NC_000913) revealed a conserved
E. coli core genome with an estimated size of 3.9 Mb (Table 3; Blattner et al., 1997; Perna et al.,
2001; Welch et al., 2002). This core genome has a G+C content of 50.8% and displays a homogeneous
codon usage pattern (Blattner et al., 1997; dos Reis et al., 2003; Perna et al., 2001; Sharp and Li,
1987; Welch et al., 2002). Besides the core genome a strain-specific flexible gene pool exists
(predictably up to 1.3 Mb) that is formed by horizontally transferred mobile genetic elements, such as
PAIs, plasmids, phages, transposons, and insertion sequences (IS; Blattner et al., 1997; Perna et al.,
2001; Welch et al., 2002). These mobile “genetic modules” facilitate rapid adaptation of E. coli to the
changing environmental conditions and hence extend the spectrum of sites that can be infected
(Hacker and Carniel, 2001; Lerat et al., 2005; Ochman et al., 2005; Ochman and Jones, 2000). The
strain specific extragenous gene pool is largely different from the set of established house keeping
genes involved in metabolic and catabolic functions and differs both in the G+C composition and the
codon usage pattern (Daubin et al., 2003; Lawrence and Ochman, 1997; Medigue et al., 1991;
Ochman et al., 2005).
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1.4.3  Pathogenicity islands
The concept of "pathogenicity island" was introduced in the late 1980s by Hacker and colleagues to
describe chromosomal gene islands (Hacker et al., 1990). Nowadays, there is a tendency towards
describing PAIs as genomic islands (GI) because most of the traditional PAI-associated genes do not
directly account for virulence and they are found in non-virulent strains too. In view of that, GIs are
classified as PAIs, fitness islands, metabolic islands, or symbiotic islands according to their
established or putative functions (Fig. 4; Carroll et al., 2004; Chouikha et al., 2006; Dobrindt et al.,
2004).
Figure 4. GIs are subclassified according to their established or putative functions as PAIs, fitness islands,
metabolic islands, or symbiotic islands.
Several GIs have been identified in ExPEC and most of the known urovirulence factors are
traditionally thought to be PAI-associated (e.g. siderophore systems and fimbrial adhesins). The model
organisms for the study of GIs of ExPEC are the UPEC isolates 536, J96, and CFT073 (Bingen-Bidois
et al., 2002; Dobrindt et al., 2003; Houdouin et al., 2002; Johnson et al., 2002). Genomic islands carry
a number of common genetic features, which are outlined below. Points i and ii are the criteria for a GI
to be termed a PAI. For a current review, see references Hochhut et al., 2005 and Schmidt and Hensel,
2004.
 i. PAI carry one or more virulence genes.
 ii. PAI are present in the genomes of pathogenic bacteria but absent from the genomes of the
non-pathogenic representatives of the same species or closely related species.
 iii. GIs occupy relatively large genomic regions; the majority of GIs are in the range of 10 to
200 kb (kilo base pair).
 iv. GIs often differ from the core genome with respect to the base composition and the codon
usage; recently acquired GIs still have the base composition and the codon usage pattern
of the donor species.
 v. GIs are frequently located adjacent to transfer-RNA (tRNA) genes; genes encoding
tRNAs are highly conserved among various bacterial species and are assumed to provide
an integration point for foreign DNA (by providing substrate for homologous
recombination or phage transduction).
 vi. GIs are frequently associated with mobile (functional or cryptic) genetic elements, like
integrases, ISs, plasmids, transposons, and bacteriophages or remnants of these elements.
In addition, GIs are often flanked by direct repeats and recognition sites for the integration
and excision of bacteriophages; the mobile genetic elements may contribute to the
instability of GIs flanked by direct repeats.
Symbiotic islands
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Metabolic
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Pathogenicity
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 vii. GIs are often unstable and are deleted with distinct frequencies; the same genetic elements
that contribute to mobilization are also responsible for intrinsic genetic instability.
 viii. GIs represent mosaic-like structures rather than homogeneous segments of horizontally
acquired DNA; during the evolution, several genetic elements have been acquired
independently from different hosts and at different time points.
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1.5  DNA microarrays in the research of extraintestinal infections caused by ExPEC
First DNA microarrays were described in the early 1990s (Schena et al., 1995). Today, the DNA and
oligonucleotide microarray technologies play increasingly important roles in life sciences and they
have been applied in various formats ranging from low-density arrays with few genes to higher density
arrays including hundreds of probes. DNA microarrays have been employed in genotyping (e.g.
phylogenetic and pathogenetic classification of bacteria, discrimination of micro-organisms in mixed
or non-cultivable samples, or drug surveillance of clinically relevant micro-organisms) and in
monitoring the transient gene expression in response to altered environmental conditions (e.g. in vitro
versus in vivo growth of a pathogen; Bryant et al., 2004; Choudhuri, 2004; Dharmadi and Gonzalez,
2004; Hofman, 2005; Stoughton, 2005).
A DNA microarray is a solid surface, such as a glass slide or silicon substrate, on which
extended DNA fragments or short DNA oligonucleotides are attached (Fig. 5; Bras et al., 2004). In the
DNA array format, DNA probes homologous with the desired gene or DNA region are generated by
PCR (polymerase chain reaction) using either complementary-DNA (cDNA) or genomic DNA as
template. These DNA probes are typically 300 to 800 nucleotides (nt) in length (Chou et al., 2004;
Schena et al., 1995). In the oligonucleotide-based arrays, short target-specific DNA probes of 20 to 80
nt in length are either synthesized prior to spotting or in situ directly on the solid substrate (Cheng et
al., 2002; Chou et al., 2004; Zarrinkar et al., 2001). It should be noted that in this thesis the
immobilized DNA molecules are referred to as “DNA probes” and the labeled DNA molecules
(chromosomal DNA) as “DNA targets”. Before array hybridization, the target DNA, which is either
chromosomal DNA (genotyping) or cDNA (gene expression), is labeled with fluorochrome dyes, such
as cyanines Cy5 (red) or Cy3 (green; Fig. 5). Multiple DNA targets labeled with miscellaneous
fluorochromes can be employed simultaneously. The DNA-DNA hybridizations and subsequent
stringency washes are performed as in the conventional Southern hybridization procedure with certain
refinements (Ausubel et al., 1989). Subsequently, the hybridized slides are scanned and the
fluorescence emission of Cy5 and Cy3 dyes are measured at wavelengths of 635 nm and 532 nm,
respectively (Fig. 5; Bilban et al., 2002). The fluorescence intensity in the close vicinity of each spot is
individually measured in order to estimate and eventually eliminate the contaminating background
emission (signal-to-noise ratio; Martinez et al., 2003). The different data sets (hybridizations) are
normalized using normalization algorithms, such as the variance stabilization normalization algorithm
developed by Huber and colleagues (Huber et al., 2002).
To date, there are several studies, which describe the use of DNA microarrays in genotyping of
pathogenic E. coli (e.g. pathoarrays) and expression profiling of infecting E. coli populations (Bekal et
al., 2003; Dobrindt et al., 2003; Fukiya et al., 2004; Korczak et al., 2005; Ochman and Santos, 2005;
Snyder et al., 2005; van Ijperen et al., 2002; Yu et al., 2004). Pathoarrays are designed for screening
of the pathotype-specific genetic markers either in defined clinical isolates or in mixed cultures, such
as in stool, blood, or cerebrospinal fluid samples (Cleven et al., 2006; Liu et al., 2005; Wang et al.,
2004; Wu et al., 2004). So far, four prototypic ExPEC pathoarrays with different sets of DNA probes
have been described (Bekal et al., 2003; Dobrindt et al., 2003; Korczak et al., 2005; van Ijperen et al.,
2002). These pilot studies showed that the ExPEC pathoarrays can be applied for differentiation of
extraintestinal and intestinal pathogenic E. coli and commensal E. coli strains (Bekal et al., 2003;
Dobrindt et al., 2003; Korczak et al., 2005; van Ijperen et al., 2002).
DNA microarrays comprised of all translatable open reading frames (ORF) of the commensal E.
coli strain MG1655 (4290 ORFs) have been applied to determine the global genetic diversity among
ExPEC, non-pathogenic E. coli, and closely related Shigella spp. The comparative genomic
Extraintestinal pathogenic Escherichia coli Introduction
22
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki
hybridizations of ExPECs and Shigella spp. with the E. coli strain MG1655 showed that the core set of
genes involved in the growth maintenance would comprise of 3100 ORFs in E. coli and 2586 ORFs in
Shigella spp. (Dobrindt et al., 2003; Fukiya et al., 2004).
One of the promising applications of DNA microarrays is the monitoring of transient gene
expression in response to an environmental stimulus (i.e. functional genomics; Balazsi et al., 2005;
Beloin et al., 2004; Gerdes et al., 2003; Hua et al., 2004; Ren et al., 2004). Snyder and colleagues
used a sophisticated array to profile gene expression of the UPEC strain CFT073 during an
experimental UTI. They identified a number of genes that were down- or upregulated in response to
altered growth environment (i.e. Luria-Bertani broth, urine, and the urinary tract; Snyder et al., 2004).
This study is discussed more closely in Chapter 1.2. As an accurate inflammatory response induced by
the host (e.g. in response to bacterial LPS) influences significantly the outcome of an UTI, monitoring
of transient gene expression of the host at the different stages of infection will most likely be of
particular importance in the future (Dou et al., 2005; Bliss et al., 2005; Higgins et al., 2003; Saban et
al., 2002).
Unfortunately, the routine use of microarrays in diagnostic laboratories is still limited due to
high costs, requirement of specialized equipment and well-trained personnel and hence sophisticated
microarray technology is so far established only in research laboratories.
Figure 5. Generation and detection of a DNA microarray. DNA probes homologous with desired DNA
regions are generated by PCR and printed on the slide surface. Subsequently, the target DNA is
fluorescently labeled and hybridized on the array. The hybridized arrays are scanned for the
fluorescence emission and the signal intensities are measured ("imaging").
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Figure 6. Suppressive subtractive hybridization
method developed by Diatchenko and
colleagues. Two cycles of hybridization ensure
elimination of the sequences shared by the
tester- and driver-strains. The DNA fragments
unique for the tester-strain are PCR amplified
using oligo-nucleotide primers specific for the
adaptor sequences ligated to the tester-DNA
prior to hybridizations.
1.6  Suppressive subtractive hybridization of genomic DNA
Diatchenko and colleagues developed the suppressive subtractive hybridization technique in 1996
(Fig. 6; Diatchenko et al., 1996). This method is based on an antecessor technique of the subtractive
genomic hybridization, where sequences present in one gene pool (tester-genome or tester-cDNA
library) are enriched at the expense of another gene pool (driver-genome or driver-cDNA library) by
the selective concentration (e.g. by affinity chromatography) of the tester-specific sequences after
hybridization of the two sequence-pools (Welcher et al., 1986). In the subtraction technique developed
by Diatchenko, the requirement for purification of the subtracted DNA fragments is circumvented by
using PCR amplification with oligonucleotide primers homologous with the linker-sequences ligated
on the tester-DNA pool (Fig. 6). These PCR primers contain long inverted terminal repeats, which
selectively suppress the PCR amplification of abundant sequences, thus balancing differences in the
abundances of individual mRNAs or genes in the genome (Diatchenko et al., 1996). Today, a few
commercial kits are available for subtraction experiments and several authors have successfully used
suppressive subtractive hybridization for identification of pathotype specific sequences in E. coli
(Bahrani-Mougeot et al., 2001; Janke et al., 2001; Miyazaki et al., 2002; Zhang and Foxman, 2003).
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2. AIMS OF THE PROJECT
At the beginning of this project in 1999, the vast genomic diversity among species E. coli was only
anticipated; the initial aim of this project was to characterize the genomic variation in ExPEC strains,
which cause urinary tract infections (i.e. UPEC). During this project, it became clear that UPEC strains
differ significantly not only from intestinal pathogenic and non-pathogenic E. coli strains but also from
each other. This extensive heterogeneity posed us a challenge to characterize the fraction of unique
DNA in two clinically relevant UPEC strains in order to learn how these flexible genomes are
assembled and which mechanisms contribute to the observed genomic mobility. Moreover, we
hypothesized that the mobile gene fraction must encode a number of novel virulence determinants,
which might contribute to the infection of an extraintestinal site (i.e. the urinary tract). As ExPEC
strains seemed to lack a common denominator (i.e. a virulence trait or traits), which could be used to
distinguish highly virulent clones from less virulent and non-pathogenic E. coli, we decided to develop
a novel algorithm, which described the probability of some combination of ExPEC virulence
determinants to specify the extraintestinal virulent phenotype.
For these purposes, the following questions were addressed:
• Do genomic contents of ExPEC strains, which belong to the same pathotype (i.e. UPEC)
and infect the same anatomical site (i.e. the urinary tract), differ from each other?
• If they do, how extensive is this variation?
• How does extragenous DNA (e.g. genomic islands) differ from the conserved E. coli core
genome, which encodes catabolic and metabolic functions?
• How are UPEC genomes assembled and how is the observed genomic mobility achieved?
• Do extragenous DNA encode putative virulence or fitness determinants, which might
contribute to the ascending urinary tract infections?
• Are there common denominators for ExPEC or UPEC?
• Is it possible to differentiate highly virulent ExPEC clones from less virulent isolates and
from commensal E. coli strains, which inhabit the gut?
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3. MATERIALS AND METHODS
The experimental methods used in this project are described in the original publications and
summarized in Table 2. References for the published methods can be found in the original publications
(see “List of original publications”). The DNA microarray technology and the suppressive subtractive
hybridization method used in this project are summarized in chapters 1.5. and 1.6. Bacterial strains,
plasmids, and cosmids are described in detail in the original publications and summarized in table 3.
The bacterial strains were stored at -80ºC until use. The oligonucleotide primer sequences used in this
project are described in the original publications and summarized in table 4.
3.1 Methods
Table 2. Methods used in this project.
Method Described and
used in study
Culture conditions
General culture conditions for E. coli I-IV
Culture conditions in bacterial matings and selection of transconjugants I
Induced iron starvation I
Methods of molecular biology
Catecholate siderophore uptake assays (feeding bioassay) I
Construction of the iroN and iroE mutant E. coli strains by the EZ::Tn-
transposon insertion
I
Dot blot hybridization I, II
Generation of cosmid libraries and selection of the cosmids of interest I, III
Isolation of chromosomal and plasmid DNA I-IV
Isolation of mRNA I
Reverse transcription PCR (RT-PCR) I
DNA sequencing I-IV
Suppressive subtractive hybridization of genomic DNA II
Microarray technology
Generation and hybridization of DNA microarrays III, IV
Imaging and analysis of the DNA microarray hybridization signals III, IV
Determination of the gene-specific threshold values III, IV
Sequence analysis and statistical tests
Gaussian approximation algorithm III, IV
K-mean clustering algorithm IV
Phylogenetic analysis of nucleotide and protein sequences I
Sequence alignment using public sequence databases I-IV
Variance stabilization normalization algorithm III, IV
Virulence gene algorithm IV
χ2 test I-IV
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3.2  Bacterial strains, plasmids, and cosmids
Table 3. Bacterial strains, plasmids, and cosmids used in this project.
Strain, plasmid, or
cosmid
Relevant characteristic(s) and description Reference Study
E. coli strain
536 Pyelonephritis, O6:K15:H31, PGa B2 Hacker et al., 1992 I-IV
A30 Cystitis, O75 Archambaud et al., 1988 IV
AD110 Cystitis, O6:K2:H1:F7, PG B2 Labigne-Roussel and Falkow, 1988 IV
BL21 Laboratory strain, PG A,
F- ompT hsdS(rB- mB) dcm+ Tetr gal λ(DE3) endA Hte (pLysS Camr)
Stratagene, La Jolla, CA, USA IV
CFT073 Pyelonephritis, O6:K2:H1, PG B2 Mobley et al., 1990 I-IV
CP9 Bacteremia, O4:K54:H5, PG B2 Russo et al., 1998 I-IV
D9 Cystitis, PG A Schubertb III, IV
DH5α Laboratory strain, PG A,
F- Φ80dlacZ∆M15∆(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-mk+)
phoA supE44-thi-1 gyrA96 relA1
Invitrogen, Paisley, UK I-IV
Do764 Cystitis PG B2 Dobrindtc III, IV
Do768 Cystitis, PG B2 Dobrindt III, IV
DSM6601 Stool, O6:K5:H1, PG B2 Nissle, 1959 I-IV
EAEC 042 Diarrhea Henderson et al., 1999 IV
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EB1 Intra-abdominal wound infection, O8:K43 Verweij-van Vught et al., 1985 IV
ECOR31 Stool, PG D Ochman and Selander, 1984; Schubert et al.,
2004
I-IV
ED2403 Cystitis, PG A Dobrindt III, IV
EDL933 Hemorrhagic diarrhea, O157:H7 O'Brien et al., 1993; Perna et al., 2001 III, IV
H5058 aroB malT tsx thi cir fiu fepA Baumler et al., 1998 I
HB101 hsdR- hsdM- recA13 supE44 lacz4 leuB6 proA2 thi-l Smr , PG A Takara, Shiga, Japan IV
HE300 Pyelonephritis, R:H-, PG A Sorsae I-IV
IHE1041 Pyelonephritis, O1:K1:H7, PG B2 Vaisanen-Rhen et al., 1984 IV
IHE1049 Pyelonephritis, O1:K1:H7, PG B2 Vaisanen-Rhen et al., 1984 IV
IHE1086 Pyelonephritis, O4:K12:H1, PG B2 Vaisanen-Rhen et al., 1984 IV
IHE1167 Pyelonephritis, O4:K12:H1, PG B2 Korhonend IV
IHE1190 Pyelonephritis, O18:K5:H7, PG B2 Vaisanen-Rhen et al., 1984 IV
IHE1210 Pyelonephritis, O1:K1:H7, PG B2 Korhonen IV
IHE1402 Pyelonephritis, O6:K2:H1, PG B2 Vaisanen-Rhen et al., 1984 IV
IHE1431 Pyelonephritis, O6:K2:H1, PG B2 Vaisanen-Rhen et al., 1984 IV
IHE3040 Newborn meningitis, O18:K1:H7, PG B1 Korhonen et al., 1985 IV
IHE3041 Newborn meningitis, O18:K1:H7, PG B2 Korhonen IV
IHE3034 Newborn meningitis, O18:K1:H7, PG B2 Korhonen et al., 1985 IV
IHE3047 Newborn meningitis, O18:K1:H7, PG B2 Korhonen et al., 1985 IV
IHE3080 Newborn meningitis, O18:K1:H7, PG B2 Korhonen et al., 1985 IV
IHE11015 Pyelonephritis, O4:K12:H7, PG B2 Korhonen IV
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IHE11020 Pyelonephritis, O6:K2:H1, PG B2 Korhonen IV
IHE11035 Pyelonephritis, O21:K14:H4, PG A Korhonen IV
IHE11048 Pyelonephritis, O75:K100:H5, PG B2 Korhonen IV
IHE11158 Pyelonephritis, O6:K13:H1, PG B2 Korhonen IV
IHE11290 Pyelonephritis, O16:K1:H6, PG B2 Korhonen IV
J96 Pyelonephritis, PG B2 Hull et al., 1981 I-IV
JS293 Chronic cystitis, PG B2,
host suffers of diabetes mellitus
Schubert I-IV
JS295 Cystitis, PG B1 Schubert I-IV
JS297 Cystitis, PG B2,
host suffers of diabetes mellitus
Schubert I-IV
JS299 Cystitis, O6:H-, PG B2 Schubert I-IV
JS304 Pyelonephritis, O1:H7, PG B1 Schubert I-IV
JS305 Pyelonephritis, PG B2 Schubert I-IV
JS309 Cystitis, PG B2 Schubert I-IV
JS322 Pyelonephritis, O77:H18, PG D Schubert I-IV
JS323 Pyelonephritis, PG B2 Schubert I-IV
JS325 Pyelonephritis, PG B2 Schubert I-IV
JS326 Pyelonephritis, PG B2 Schubert I-IV
JS355 Pyelonephritis, PG B2 Schubert I-IV
MG1655 Non-pathogenic K-12 strain, PG A Blattner et al., 1997 I-IV
Nu14 Cystitis, O18:K1:H7, PG B2 Johnson et al., 2001 I-IV
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RS218 Newborn meningitis, O18:K1:H7, PG B2 Achtman et al., 1983 I-IV
S17-1λPIR Laboratory strain,
tpr Smr recA thi pro hsdM+ RP4-2-Tc::Mu::Km Tn7 pir, hsdR
Alexeyev and Shokolenko, 1995 I
S5 Bacteriemia, O15:K+:H21 Morris and Drouin, 2004 IV
S2207 Catheter-associated cystitis, PG A Schubert I-IV
S2265 Catheter-associated pyelonephritis, PG B2 Schubert I-IV
S2287 Catheter-associated pyelonephritis, PG D Schubert I-IV
S2288 Catheter-associated pyelonephritis, PG B1 Schubert I-IV
S2413 Urosepsis, PG B2 Schubert I-IV
S2523 Urosepsis, PG B2 Schubert I-IV
S2536 Urosepsis, PG D Schubert I-IV
S2572 Urosepsis, PG D Schubert I-IV
S2608 Cystitis, PG A Schubert I-IV
S27710 Pyelonephritis, PG B2 Schubert I-IV
S4000 Stool, PG D Schubert I-IV
S4005 Stool, PG B1 Schubert I-IV
S4010 Stool, PG B2 Schubert I-IV
S4011 Stool, PG B2 Schubert I-IV
S4012 Stool, PG A Schubert I-IV
S4013 Stool, PG D Schubert I-IV
S4014 Stool, PG D Schubert I-IV
S4015 Stool, PG B1 Schubert I-IV
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S4016 Stool, PG B1 Schubert I-IV
S4017 Stool, PG B1 Schubert I-IV
S4020 Stool, PG B2 Schubert I-IV
S4021 Stool, PG B2 Schubert I-IV
S4022 Stool, PG D Schubert I-IV
S4023 Stool, PG A Schubert I-IV
S4026 Stool, PG A Schubert I-IV
S4039 Stool, PG B1 Schubert I-IV
S4050 Stool, PG B1 Schubert I-IV
S4134 Stool, PG A Schubert I-IV
S4136 Stool, PG A Schubert I-IV
S4138 Stool, PG A Schubert I-IV
S4140 Stool, PG A Schubert I-IV
S4141 Stool, PG A Schubert I-IV
S4147 Stool, PG B1 Schubert I-IV
S4148 Stool, PG A Schubert I-IV
S4149 Stool, PG B2 Schubert I-IV
S4151 Stool, PG B1 Schubert I-IV
S4152 Stool, PG A Schubert I-IV
S4153 Stool, PG B1 Schubert I-IV
S4158 Stool, PG B1 Schubert I-IV
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TH2 Laboratory strain, PG A,
supE44 hsdS20 (rB-mB-) recA13 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-
1 thi trpR624
Takara I
TOP10 Laboratory strain, PG A,
F- mcrA(mrr-hsdRMS-mcrBC)Φ80lac∆M15∆lacX74 recA1 ara∆139∆(ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen I-IV
XL-1 Blue MRF´ Laboratory strain, PG A,
∆(mcrA)183∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96
relA1 lac [F´ proAB lacIqZ∆M15 Tn10 (TetR)]
Stratagene I, IV
Plasmids and cosmids:
p300 Plasmid of the UPEC strain HE300 carrying iroBCDEN gene cluster Sorsa I, IV
pSuperCos1 Cosmid vector Stratagene I, III
pJS332 Cosmid vector pSuperCos1 with 32 kb inserted DNA originating from
plasmid p300
Sorsa I
pCR4-TOPO for
sequencing
TA cloning vector Invitrogen I, II
p[iroEN] Cloning vector pCR4-TOPO with iroEN genes originating from plasmid
p300
Sorsa I
p[iroBCDE] Cloning vector pCR4-TOPO with iroBCDE genes originating from plasmid
p300
Sorsa I
p[iroN:Tpr-iroE] Plasmid p[iroEN] with trimethoprim cassette inserted into iroN gene Sorsa I
p[iroN-iroE:Tpr] Plasmid p[iroEN] with trimethoprim cassette inserted into iroE gene Sorsa I
pJS448 Cosmid vector pSuperCos1 carrying chromosomal DNA of the UPEC strain
JS299
Sorsa III, IV
pJS666 Cosmid vector pSuperCos1 carrying chromosomal DNA of the UPEC strain
JS299
Sorsa III, IV
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pPJS700 Cosmid vector pSuperCos1 carrying chromosomal DNA of the UPEC strain
JS299
Sorsa III, IV
pJS706 Cosmid vector pSuperCos1 carrying chromosomal DNA of the UPEC strain
JS299
Sorsa III, IV
a Phylogenetic group (PG) defined by the method described by Clermont et al. 2000
b Strain kindly provided by Dr. Sören Schubert, Max von Pettenkofer-Institut, University of Munich, Germany
c Strain kindly provided by Dr. Ulrich Dobrindt, Department of Infection Biology, University of Würzburg, Germany
d Strain kindly provided by Dr. Timo Korhonen, Department of Biological and Environmental Sciences, University of Helsinki, Finland
e This project
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3.3  Oligonucleotide primer sequences
Table 4. Oligonucleotide primer sequences used in the project.
Target gene Accession
number or
reference
Template source Forward primer
5'→3'
Reverse primer
5'→3'
Study
Homo sapiens
β-actin M28424 Human CTGTGGCATCCACGAAACTA AGCAATGATCTTGATCCTTCA IV
E. coli
adk NC_004431 CFT073 ATTCTGCTTGGCGCTCCGGG CCGTCAACTTTCGCGTATTT IV
afa/draBC Johnson and
Stell, 2000
A30 GGCAGAGGGCCGGCAACAGGC CCCGTAACGCGCCAGCATCTC IV
afaD3 X76688 A30 CGGAGATGAACGGGAGTATAAG GGTATTCACCAGGAGCAATGTC IV
afaD8 AF072900 IH11165 GAGTCTTAATACCAGTGATGGAAGG AATATTATGAGCATTCTCCGCTAAC IV
aufA AE016768 CFT073 CCATTATTCGTCGTACCTTTGG TATCCCAGGCTCACTGATATGG IV
aufC AE016768 CFT073 GAAAGGTTGCGATACACTAGCC ATTTCAGGGGGAATTAATTTGG IV
aufG AE016768 CFT073 TAGTTTTCCACCAATCTGAACG TAAATATTCAGGTTCCGCAAGG IV
c2397serU Island AE016762 CFT073 TGCTCACATTGTTGAAAGTTCC TCAAGGTAGCTGTTTGACATGG IV
c2398serU Island AE016762 CFT073 TCATATCCCATGCAAAAGAGG AGTTTGCAGTGCCATTTTATCC IV
c2400serU Island AE016762 CFT073 AAGATGGATTCAAGGTCATTGC ATCCGGCATTGTAAGAAAAGC IV
c2416serU Island AE016762 CFT073 GGATTTACTGCGTAGGTTCTGG ATCAAAGGAAATGGATTGTTGG IV
c3607PAI II AF447814 CFT073 GCTCGGTTGAAAGTGCC TCTCAGCGTTGCATGG IV
c4836 AE016770 CFT073 TGGGTCGTATTCAGCGG GGGTTCGCAACTCACG IV
cadA AE016771 MG1655 GTGGGATACCACCAAGAATACC TTCTGTACTCCTGGTCACATGG IV
cdtB AJ508930 S5 TGCTCTGGTTAGCAATCG GCTTGTAGCGGAAATGG IV
chuA NC_004431 CFT073 CTTCAGCCACTGATTTGC GCGGTTTCACCATTGC IV
cnf1 AF483829 J96 GACGTTGATGGCTCAGG ATTGCCTCTTATCATACGGC IV
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cnf2 U01097 S5 ATTCCTGATGAGGCTCCAGTAG CTCGAGCAGAATTTGATACACG IV
csgA NC_000913 MG1655 AGCAATCGTATTCTCCGGTAGC GTTACCAAAGCCAACCTGAGTC IV
cvaC AJ223631 EB1 AGATTCTGTTTCTGGTGGTGCT TTCGGGTTTTTGCTTAATTGTT IV
dsdA NC_004431 CFT073 TGGAATACGAGCAAGATTATGG TGGACGCCTAATAACATACACG IV
dsdC NC_004431 CFT073 GATATCGGCGTGTAAAGTCACC CCCTTCGTGAAATAAGAAATCG IV
east1 AF411067 EAEC 042 CGAACGCTTCCAGTGC AACAAATCGGTGTTCCTGG IV
entF NC_004431 CFT073 TAGCGATATCCCCAATTTAACC GGCTTCACCACTACAGAAAACC IV
fecD AE016759 CFT073 ATTATGCCTGCTATTGCTACCG CACCCAGTTACCGTCAATTACC IV
fepA NC_004431 CFT073 GAACTCCAGACCAATCTCCTTG GTACAGAGTGGAATCAGCAACG IV
fimH AE016771 CFT073 CGGCGTGTTATCTAGTTTTTCC TAGGTAATACCCCAGGTTTTGG IV
focA AF29820 AD110 GGCTGTATTTTCAGCTCTGACC AGCTTGCAGTTCCATCTAAAGG IV
fyuA NC_003143 536 TGCAGCTTTACTCTGGCC TAGACGGAAATGTTCATCCG IV
hbp AJ223631 EB1 TCCCAGTTCGTGCTTACG ATTTGTCATGCGTACAGACC IV
hek AJ494981 536 GGAAGTCATAGTACGCATTCAGC TCTGTGGTGTCACTTTCAGACC IV
hlyA AJ494981 536 ATGCAGATACCGGAACTAAAGC CTGAAATTATCCCCGTAACAGC IV
ibeA AF289032 RS218 AAGCAGGGCAATAATTTACTCG TTTCCTTTCGCAAGACTTTACC IV
iha AF447814 CFT073 TTGATGGTGTTCGTCAGG TATCATAACGCTGCCGG IV
ilvD NC_004431 CFT073 GACCAAACGTTACTACGAACAGG GTCGTATTGTTCCAGTGTTTGC IV
ireA1 AF320691 CP9 TGGGAAATTTGGTAACTCAACC TCCGGTTTTCTTGACTCGTAAT IV
ireA2 AF320691 CP9 TGACGAAAGTCTCAATGGC TACATTAGCCCAATAACGGC IV
iroBCDEN AY205565 HE300 TGGTCAGGTTGCGGAGGCTAT'- GCGAAGGCGAGACTATCAGGA II
iroD AY205565 HE300 GGGGCTGAGAAATATCAACATC GAAGATGAGCGAGAAGTGACCT IV
iroE AY205565 HE300 CGATCGATATTCAGTCCCTGTT CGATAAAGGCTCCGTGTTTTAC IV
iroN AY205565 HE300 CAAAACAGTTCTTCCAGTGCAG GAACCGGCTCAATGTTATCTTC IV
iss AY205565 HE300 TTCCAGCGGAGTATAGATGC ATCACATAGGATTCTGCCG IV
iucC NC_004431 CFT073 TTGATAAAATCGCCTTTCAGGT ACCAGGAAATGCTTGGTGTTAT IV
iutA NC_004431 CFT073 CAGACCAGCATTGAACAGAAAG CAGTACGGCATGAAACTGACTC IV
mchF AF302690 536 TATTCGTCTGGTGACATACGG TTTCATGTAGTGCAATATCTGC IV
mdh NC_004431 CFT073 GGCGATATCTTTCTTCAGCG ATGAAAGTCGCAGTCCTC IV
modD NC_004431 CFT073 TTTGTCGAGCTGAAGTACG TTACCCTGATGGCAATATCG IV
ompT NC_004431 CFT073 TTCATCGTTATCAAATGCTTCC ACACAACTCAATTATGCCAACG IV
matB AF325731 IHE3034 TCTATTTGACGTGGCTATCGAG TAGCGTCGAACTGTACGCTAAC IV
c1648prrA-modD-Island AF081283 CFT073 GTATAGACGCGAAGCCG AATTGACCTGCAAGGCG IV
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orf4PAI II AJ494981 536 GCCACTCCCAGAATTACG TCCGTCACTTGCCATACC IV
orf40PAI II AJ494981 536 GGAGGCAATCACCGC ACAGTGGTCGGGATACG IV
orf41PAI II AJ494981 536 TTACGGGCAGGTCTCC ACAACTGGTTTGTCCGC IV
orf11PAI III X16664 536 TTATTGCACACAGAGAAACTACG TCATTTCAACACCTTCGC IV
orf12PAI III X16664 536 CTTCACAAATCTTATAGCGAAGG CCGCAGACGAAGAGGC IV
orf36PAI III X16664 536 CAGTTAAAAGGCGGATATTTCG AGAGTTACTGACGCCTCAAAGC IV
orf29p300 AY205565 HE300 GATCACAACAAGCCGGATGT AGCCAATGAGCGCCAGA I, IV
orf24 (iss)p300 AY205565 HE300 GCTTCCAGCGGAGTATAGAT CGCTCTGGCAATGCTTATT I, IV
P761 (scrA) DQ079865 JS299 AGCGGCTTCAGTAATCCCTA CTTATCTTGGCGCGACAT III, IV
P762 (scrY) DQ079865 JS299 CCACTCTCCGCCAGTA GCCAGCAATTCTCGCACAAA III, IV
P763 (ukoI) DQ079860 JS299 ATGTCATACTCTTTCGCATT CAAGAAGCCGTGGAC III, IV
P765 (ukoC) DQ079861 JS299 GGCATTACTTCTGAGTATTG ATTCATAATCAGGACCAGAT III, IV
P767 (ukoE2) DQ079861 JS299 GTTTCCCATTCCTTGACTGC GCGGATGAGATTGCCTATG III, IV
P769 (c2163) DQ079863 JS299 AATTTCTGTCTGGATTACGG GACGACGAAGATCAGTGG III, IV
P700 (ukoA) X16664 536 GTTGCCCGGGGTGATACATCC TCACTGAGCTGTAATCAAT III, IV
P774 (ukoE1) DQ079861 JS299 GTTTGAGGTCTGACGCGATA AGTGCGCTTGCTGATACCAG III, IV
P776 (ukoJ) DQ079860 JS299 CGCTCTCAATCACTGGAA CACGCTGACATCGGTGTTGT III, IV
P780 (scrB) DQ079865 JS299 ACTGGCAGGAAGATAACGA CAGTACATTGCCATTGGTCA III, IV
P785 (ukoK) DQ079863 JS299 TTCTCTGACTTCTGGCAACC TTATGTTCATGGCAGGGAA III, IV
P792 (ukoF) DQ079860 JS299 GGCCACGCAGACGCAGGGAG GGGCGACCACACGGTGCT III, IV
papA NC_004431 CFT073 AAGTCAGGTTGAAATTCGC CACCATGTGGTATTGATGC IV
papF AE016771 CFT073 GCTGTCACTCTGTAACCATTTCC TTATATCGTTGCTTCTGACATCG IV
papGI AF240678 CP9 AAGGTTATTGACCAACCTCAGC CTGGCAAAAAGACCCTGAATAC IV
papGII AE016771 CFT073 CGTCTGACTGAGAAATTTGACG TTCTTACCATGGCTGTATGTCG IV
papGIII AF237473 CP9 ATGGATTTACCTGGACTCATGG AACGAAGAAGGGATTTTGTAGC IV
picU AF097644 EAEC 042 GTTACCCCGTATCTGCTGAATC CCAGTAAAAGCTGGGATTTTTG IV
prfG AJ494981 536 CCTTCCTAAGGGGGATTATACG ACCATCTCATCGTTGTCTCTCC IV
prrA U85771 CFT073 TGCGGTCATAGTACGAAAGC TTACAGCGACGGTGCC IV
sat NC_004431 CFT073 CTCGTTGTCATGGTGAACG CGTATGGGTGATCTGCG IV
sfa/foc Johnson et al.,
2005b
J96 CTCCGGAGAACTGGGTGCATCTTAC CGGAGGAGTAATTACAAACCTGGCA IV
sfaA X16664 536 TTTAAGGGGGAAGTTGTTGATG TGCCTGGAAAGGAATTTTATTG IV
sfaS X16664 536 GGATACGACGATTACTGTGACG TAACCTGGCCTTTACTCACTGC IV
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SAK450 AY428160 JS322 ATCCCCTCTGGCCGTGGTTC AGAAGTCATCCGCGAAATAGC II, IV
SAK448 DQ679231 JS322 ATAGGCGCGTGATACAGG TAATAACGTAAAATCAATGCTTCC II, IV
SAK464 DQ409208 JS322 GCCAGGGCAGAGCTTGTTTTA ATGGTAATAATAGATGTTTTC II, IV
SPL107 AY428158 HE300 GATACATAGCTTTTGGGTCTG GCTGCAGGGTAGGGTGAT I, II, IV
SPL135 DQ662933 HE300 AGTTATTTATCTTTGAGTGG CCAAGCATGCGGGTGTG II, IV
SPL220 DQ409207 JS304 GGGCTTCATCAGTAATCAGGGTAA TGGTCCAGGCACAGATAGAAGTAG II, IV
SPL247 AL627270 JS304 ATGCGGTTTATCTCAATCTT GGTACTGGGCTTCCGTTGCTGGTT II, IV
SPL284 DQ409206 JS304 GCGGCCGAGGTACTGGTTCC CATGATGCCGTTTTCTGTAT II, IV
SPL341
(ukoD/E)
DQ079861 JS299 CGTATTTTGTAAAACAGTATA AGCGAGGGAACAGTTCAGGG II, III,
IV
SPL345 AY428148 JS299 GACTATCGCTCGAACCTCCTCCTT TTGATTATGCCTTACGCCAGATGC II, IV
SPL346 (ukoG) DQ079860 JS299 GTTGATATGAAAATCAGGGG CAAACCGCGCTGAATGGTGATT II, III,
IV
SPL359
(ukoK/c2163)
DQ079863 JS299 GTACCCTTGTTCTGCCGATTT GGTGTTTCAAAATGATTTAGG II, III,
IV
SPL373 (scrB) DQ079865 JS299 TACCATTGGCTGTTGTGCTTC GTACGACCGTAATGGTTGTT II, III,
IV
SPL386 DQ409201 JS299 TCAGGTATATTCAGTGGCGTCAGT TATTGAAGGCGCGGACGACCAT II, IV
SPL395 (ukoH) DQ079860 JS299 CCTAACAATGCCAGAAGTGT ATTATGGTTATGGTAAGCTAT II, III,
IV
SPL764 DQ079860 JS299 GTCCAGTTCGGCAGTCCAC TCGCAGTGTCATTCCCGTAT II, IV
T3/T7 Evans et al.,
1989
Standard cloning
vectors
ATTAACCCTCACTAAAG AATACGACTCACTATAG II, II, III
tonB NC_004431 CFT073 GATTTCTGTCACGATGGTTGC CTTGGCTGAGAGGATTTGTACG IV
usp AB056440 536 TGACATTCACGGCAAGC CTCCTTCAGGTAAACATAGATGG IV
ydfBp300 AY205565 HE300 ATATCACGGGAAAGGAAGCAC GTCCGGCAAGGTTTATCA II
yjaA NC_000913 MG1655 TGAAGTGTCAGGAGACGC GAGTACCGCTGATTGCG IV
Extraintestinal pathogenic Escherichia coli
37
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki
3.4 Nucleotide sequence accession numbers of the sequences
Table 5. The nucleotide sequence accession numbers (NCBI) of the sequences described in this
project.
Sequence designation Accession number Study
Cosmid p332 AY205565 I, IV
Cosmid pJS448 DQ079861 III, IV
Cosmid pJS666 DQ079860 III, IV
Cosmid pJS700 DQ079863 III, IV
Cosmid pJS706 DQ079865 III, IV
Subtraction fragment SAK448 DQ679231 II, IV
Subtraction fragment SAK450 AY428160 II, IV
Subtraction fragment SAK464 DQ409208 II, IV
Subtraction fragment SPL107 AY428158 II, IV
Subtraction fragment SPL135 DQ662933 II, IV
Subtraction fragment SPL220 DQ409207 II, IV
Subtraction fragment SPL247 AL627270 II, IV
Subtraction fragment SPL284 DQ409206 II, IV
Subtraction fragment SPL341 DQ409205 II, IV
Subtraction fragment SPL345 AY428148 II, IV
Subtraction fragment SPL346 DQ409204 II, IV
Subtraction fragment SPL359 DQ409203 II, IV
Subtraction fragment SPL373 DQ409202 II, IV
Subtraction fragment SPL386 DQ409201 II, IV
Subtraction fragment SPL395 DQ409200 II, IV
Subtraction fragment SPL764 DQ079860 II, IV
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4. RESULTS AND DISCUSSION
4.1 Analysis of genomic variation of uropathogenic E. coli (UPEC; Study II)
ExPEC are a diverse group of E. coli strains, which inhabit the gut, and occasionally infect different
extraintestinal sites, such as the meninges, the blood stream, and the urinary tract. Since beginning of
the century, it is known that the ability of these strains to cause a disease is dependent upon specific
gene repertoires (i.e. virulence factors). Although a number of such virulence factors have been
identified in these strains, none of the factors is uniquely known to define these pathogens. Even if
whole-genome comparisons of E. coli strains causing different diseases (i.e. intestinal and
extraintestinal infections) have shown great differences in gene contents (Chen et al., 2006; Perna et
al., 2001; Welch et al., 2002), there is growing epidemiological, clinical, and experimental evidence,
however, to suggest that differences exist even within ExPEC strains that cause the same disease and
target the same host tissues (Dobrindt et al., 2003; Johnson et al., 2005b; Johnson et al. 2005d; Russo
and Johnson, 2003). To identify potential virulence genes or genetic markers of ExPEC, we used
genomic subtractive hybridization to determine genetic differences between four clinical UPEC
isolates, an archetypal UPEC isolate, and a commensal E. coli isolate. Evaluation of the degree of
similarity between these five strains, which cause the same disease, revealed a high degree of
diversity, with only a few shared sequences. Subsequently, additional E. coli strains of clinical and
fecal origin were screened by dot blot hybridization, and the results provided further evidence for the
existence of a high degree of genome plasticity among the ExPEC pathogroup. In addition, we
identified yet unknown sequences associated with the UPEC phenotype, which might be of medical
importance in that they could serve as valuable genetic markers to identify and discriminate potentially
pathogenic UPEC strains from less pathogenic UPEC isolates and from the commensal E. coli strains
belonging to the normal intestinal flora.
4.1.1  Genomic subtraction of the UPEC strains HE300, JS299, JS304, and JS322
Genomic DNA of four previously uncharacterized UPEC isolates HE300, JS299, JS304, and JS322
(tester-strains) was each subtracted from the chromosomes of the archetypal UPEC strain CFT073 and
the commensal E. coli strain MG1655 (driver-strains; Blattner et al., 1997; Welch et al., 2002) using
the suppressive subtractive hybridization method (Diatchenko et al., 1996). The driver-strains CFT073
and MG1655 are well-characterized strains representing UPEC and non-pathogenic E. coli,
respectively. The genomic sequences of these strains are available at the public sequence databases of
the NCBI and the EBI, which allowed direct sequence comparisons. The suppressive subtractive
hybridization method is discussed in detail in chapter 1.6.
We sequenced and characterized a total number of 384 subtraction fragments originating from
four separate subtraction fragment pools (Table 6). Of these 384 fragments, 172 (45%) revealed
sequences specific for the four tester-strains and were absent from the genomes of the driver-strains
CFT073 and MG1655. In addition, a half of the tester-specific subtraction fragments (n=86) was
shown to be highly homologous (>85% nucleotide sequence identity) with sequences deposited in the
public nucleotide databases (Table 6). These 86 sequences represented mobile genetic elements,
including bacteriophages, transposable elements (n=10), and E. coli and Salmonella sp. plasmids
(n=27), GIs of the UPEC strain 536 (n=22; Dobrindt et al., 2002), S. flexneri 2a strain YSH600 (n=3:
Turner et al., 2003), and the EHEC strain EDL933 (n=14; Perna et al., 2001) as well as other genomic
loci (n=10; Table 6).
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Table 6. Summary of the 384 subtraction fragments obtained from the UPEC strains HE300,
JS299, JS304, and JS322.
Number of sequences (%)
Subtraction
library
Clinical
characteristics
PG
groupa
Tester-
specific
>85%
homologyb
<85%
homologyb
No
homology
HE300 Pyelonephritis A 34 (100%)c 17 (50%) 14 (41%) 3 (9%)
JS299 Cystitis B2 62 (100%) 32 (52%) 29 (47%) 1 (1%)
JS304 Pyelonephritis B2 42 (100%) 25 (60%) 13 (31%) 4 (9%)
JS322 Pyelonephritis D 34 (100%) 12 (35%) 21 (62%) 1 (3%)
Total 172 (100%)d 86 (50%) 77 (45%) 9 (5%)
a Phylogenetic group (PG) defined by the triplex-PCR method described by Clermont et al. 2000
b Percentage of the homology regarding to the total sequence length
c Percentage relating to the total number of sequences in a subtraction library
d Percentage relating to the total number of sequences in the four subtraction libraries
Interestingly, each of the four UPEC strains used as tester-strains (HE300, JS299, JS304, and
JS322) gave a distinct pattern of subtraction fragments with regard to the origin of their respective
homologue (Table 7). The pyelonephritogenic E. coli tester-strain HE300, which belonged to the PG
A, revealed almost exclusively subtraction fragments, which were highly homologous (>95% identity)
with the S. enterica serotype Typhimurium plasmid pR64 (Gyohda et al., 2004) and different E. coli
plasmids. Subtraction of the cystitis strain JS299 (PG B2) essentially generated sequences associated
with the PAIs I, II, and III of the UPEC strain 536. Subtraction library of the pyelonephritogenic strain
JS304 (PG B2) revealed DNA fragments similar to the genomic DNA of Shigella spp. and the EHEC
strain EDL922. Finally, subtraction library of the pyelonephritogenic strain JS322 (PG D) consisted
mainly of sequences homologous with the chromosome of strain EDL922. Even though only a few
UPEC strains have been reported to possess plasmids (Leflon-Guibout et al., 2004; Ojo et al., 2003;
Rodriguez-Siek et al., 2005), half of the strain-specific sequences (n=27) originating from strains
HE300, JS304, and JS322 were highly similar to conjugative plasmids described in E. coli, Klebsiella
pneumoniae, Shigella spp., and Salmonella sp. (Table 7). The second large category of subtraction
fragments (n=14) was homologous with the GIs of EHEC. These subtraction fragments were detected
in all UPEC strains studied (Table 7).
Table 7. Summary of the 86 subtraction fragments highly homologous (>85%) with known
sequences deposited in the public sequence databases (n=86)
Number of sequences (%)
Subtraction
library
Total Plasmids Mobile
genetic
elements
UPEC
GIs
EHEC
GIs
Shigella
GIs
Others
HE300 17 (100%)a 10 (58%) 3 (18%) 0 (0%) 2 (12%) 0 (0%) 2 (12%)
JS299 32 (100%) 0 (0%) 0 (0%) 22 (69%) 2 (6%) 0 (0%) 8 (25%)
JS304 25 (100%) 15 (60%) 4 (16%) 0 (0%) 3 (12%) 3 (12%) 0 (0%)
JS322 12 (100%) 2 (17%) 3 (25%) 0 (0%) 7 (58%) 0 (0%) 0 (0%)
Total 86 (100%)b 27 (31%) 10 (12%) 22 (26%) 14 (16%) 3 (3%) 10 (12%)
a Percentage relating to the sequence number of highly homologous sequences in a subtraction library
b Percentage relating to the sequence number of highly homologous sequences in the four subtraction libraries
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Another half of the tester-specific subtraction fragments (n=86) displayed either low (55% to
82% identity; n=77) or no homology (n=9) with sequences in the public nucleotide databases (Table
6). These DNA fragments represented the "low homology fraction" and exhibited short sequence
stretches related to the chromosome of the UPEC strain CFT073 (n=10) as well as to putative genes of
bacteriophages, prophages, and GIs of the EHEC strain EDL933 (n=11; Table 8). However, majority
of the tester-specific subtraction fragments with low homology (n=56) were similar to sequences of 39
different bacterial species, both Gram-negative and Gram-positive. Interestingly, 51 subtraction
fragments (59%) shared short sequences with putative protein coding genes with conserved functional
domains. This might indicate the presence of novel groups of genes with conserved function (Table 8).
Table 8. Summary of the 86 subtraction fragments with low (<85%) or no sequence homology
with known sequences deposited in the public sequence databases (n=86)
Number of sequences (%)
Subtraction
library
Total Conserved
genes
EHEC GIs or
bacteriophages
Intergenic
region
No homology
HE300 17 (100%)a 8 (46%) 3 (18%) 3 (18%) 3 (18%)
JS299 30 (100%) 18 (60%) 6 (20%) 5 (17%) 1 (3%)
JS304 17 (100%) 8 (46%) 1 (6%) 4 (24%) 4 (24%)
JS322 22 (100%) 17 (77%) 1 (5%) 3 (13%) 1 (5%)
Total 86 (100%)b 51 (59%) 11 (13%) 15 (17%) 9 (11%)
a Percentage relating to the sequence number of low homology sequences in a subtraction library
b Percentage relating to the sequence number of low homology sequences in the four subtraction libraries
4.1.2  Virulence association study of the 86 subtraction fragments showing no or only
low homology with known sequences deposited in the public databases
Subtractive hybridization of the UPEC strains HE300, JS299, JS304, and JS322 with strains CFT073
and MG1655 yielded a pool of 86 novel DNA fragments, which had no or only low homology with
known sequences in the public databases (Table 8). In order to determine if these sequences were
associated with the UPEC phenotype, we performed dot blot hybridizations of chromosomal DNA
(Ausubel et al., 1989) to look for the presence of the specific sequences in 90 additional strains of the
ExPEC pathotype and fecal E. coli. The results indicated that among the 86 sequences examined, 12
sequences were significantly associated (P<0.05) with ExPEC strains when compared to commensal
E. coli strains isolated from stool samples (Table 9). Interestingly, two subtraction fragments SPL135
and SPL345, which were recovered from the UPEC strains HE300 and JS299, respectively, were
significantly more prevalent among strains of the commensal phenotype. Reliability of the dot
hybridizations in the case of the most prominent virulence gene candidates (i. e. regarding to their
prevalence among ExPECs and commensal E. coli isolates, and their putative function in bacterial
virulence) was further validated by a DNA microarray analysis (Study IV).
Interestingly, only few ExPEC-associated sequences were shared by the five UPEC strains
even though they cause clinically similar diseases. In addition, most of the subtraction fragments were
nonuniformly distributed among ExPEC strains (e.g. not according to the phylogenetic distribution or
the clinical characteristics of strains) or were present in only a relatively small subset of strains;
therefore, they may have been acquired separately by rather recent horizontal gene transfers. This
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comparison of genomic differences between fecal E. coli and highly pathogenic ExPEC isolates
predicted potential virulence-associated elements, whose characterization could facilitate identification
of factors responsible, in part, for the UPEC pathogenicity. To further describe the DNA regions
adjacent to five ExPEC-associated subtraction fragments; we constructed cosmid libraries of the total
DNA of the UPEC strains HE300 and JS299. Using the ExPEC-associated subtraction fragments
SPL107, SPL341, SPL359, SPL373, and SPL395 (Table 9; highlighted with an asterisk) as DNA
probes to screen the cosmid libraries HE300 (SPL107) and JS299 (SPL341, SPL359, SPL373, and
SPL395), five novel cosmid clones were identified. These five cosmids were partially sequenced and
characterized and the structural and the epidemiological data are presented in studies I and III.
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Table 9. BlastN (NCBI) homology search of the 14 subtraction fragments highly associated (P<0.05) with the extraintestinal virulent or the commensal
E. coli phenotype
Subtraction
fragment
Size (nt) Origina Sequence homology or designation Source Accession numberb Association Pc
SAK448 374 JS322 ratA, putative outer membrane protein E. coli CFT073 AE014075 0.05
SAK450 347 JS322 blr0961, hypothetical protein Bradyrhizobium japonicum AP005938 0.01
SPL107* 156 HE300 lin0414, hypothetical protein Listeria innocua AL596164 0.007
SPL135 430 HE300 sso_0233, hypothetical Hcp-like protein S. sonnei CP000038 <0.001
SPL220 735 JS304 estA, ABC transporter E. coli A2363 pAPEC-ColV AY545598 0.01
SPL247 199 JS304 ST41626, tail core protein S. enterica AL627270 0.01
SPL284 572 JS304 16S ribosomal DNA Caulobacter sp. AY568471 0.01
SPL341* 606 JS299 No homology 0.06d
SPL345 557 JS299 No homology <0.001
SPL346 230 JS299 Intergenic region Nostoc sp. BA000019 0.001
SPL359* 374 JS299 16S ribosomal DNA Acinetobacter radioresistens AY568469 0.1d
SPL373* 234 JS299 ygcF, hypothetical protein E. coli T19 AJ639630 0.004
SPL386 512 JS299 16S ribosomal DNA Acinetobacter radioresistens AY568469 <0.001
SPL395* 589 JS299 16S ribosomal DNA Uncultured bacterium AB128887 <0.001
a The UPEC origin of a subtraction fragment
b Accession number of the respective homologue
c Significance of association with the extraintestinal virulent or commensal E. coli phenotype was determined by a dot blot hybridization assay and by a DNA microarray analysis. Using χ2 test a P value of
<0.05 was considered as statistically significant.
d The subtraction fragments SPL341 and SPL359 showed significant association with the ExPEC strain collection used in the dot blot hybridization analysis (data not shown)
* Subtraction fragments used as DNA probes to screen the cosmid libraries of the UPEC strains HE300 and JS299
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4.1.3 The key aspect of the UPEC research; the UPEC pathogroup is a highly diverse
group of strains with a considerable amount of unknown DNA
The genome sequence determination of UPEC and EHEC, and the genomic comparison with a
commensal E. coli strain MG1655 revealed that the E. coli chromosome is comprised of a 4.1 Mb
backbone chromosome common to all E. coli isolates and of up to 1.4 Mb strain specific sequences.
Strain specific sequences are inserted at various sites on the chromosome backbone, and encode strain
specific genes, many of which are virulence related (e.g. the type III secretion system of intestinal
pathogenic E. coli; Bergthorsson and Ochman, 1998; Blattner et al., 1997; Dobrindt and Hacker, 2001;
Perna et al., 2001; Welch et al., 2002).
In this study, we analyzed genomes of four ExPEC strains, which presented similar pathotypes
(i.e. UPEC) and infected the same anatomical site (i.e. the urinary tract) by a whole genome genome
comparison analysis called suppressive subtractive hybridization. In this analysis, we hybridized
genomic sequences of four clinical UPEC isolates (HE300, JS299, JS304, and JS322) with
chromosomes of the archetypical UPEC strain CFT073 and the commensal E. coli strain MG1655, and
searched for DNA fragments unique for the four unknown UPEC strains. This analysis provided a
good view on the genomic variety of UPEC, and revealed that there is an unexpectedly high degree of
diversity among UPEC strains; the subtraction libraries of the UPEC strains differed not only from the
commensal E. coli strain MG1655 but also from the archetypal UPEC strain CFT073 and from each
other. The subtractions of some strains largely resulted in PAI-associated subtraction fragments,
whereas other strains gave DNA fragments homologous with the genomic DNA of EHEC or plasmids
of E. coli and Salmonella sp.
The obtained sequences were divided into three categories, as shown in table 6. In summary, the
first category included 170 sequences, which were shared either by the four clinical UPEC isolates and
by strain CFT073 or by strain MG1655. These sequences were homologous with the E. coli core
genome or with putative or verified ExPEC virulence factors, such as components of iron uptake
systems, toxins, and fimbriae. The second category included 86 sequences, which were absent from
the driver strains, but were highly homologous (>85%) with known sequences in the public databases
(Table 6). These sequences represented diverse ExPEC virulence genes as well as mobile genetic
elements such as bacteriophages, transposons, plasmids, and genomic islands (Table 7). The third
category included 86 sequences with no known function that could be divided into two types:
fragments with similarity to sequences of unknown function (e.g. conserved hypothetical proteins) and
fragments for which no similarity was found (Table 8).
None of the known ExPEC virulence determinants was uniformly found in all the five UPEC
strains tested. This and the fact that only 75% of the subtracted sequences were previously
characterized indicated that there is substantial genomic variability in gene content even among
“typical” UPEC strains with similar pathogenic properties. Secondly, it suggested that the UPEC
pathogenesis is a complex phenomenon resulting from a combination of gene products rather than
being determined by a single locus. The presence of novel sequences in highly virulent UPEC strains,
which are significantly associated with fecal E. coli, implied that adaptation to diverse environmental
niches (i.e. the gut and the urinary tract) might be the driving force for the genetic variation of the
ExPEC genomes. Moreover, the striking extent of genome variation in this set of isolates suggested
that analysis of UPEC and other ExPEC isolates with a broader pathogenic representation might reveal
even greater variation than that found in the current study.
A large fraction of DNA sequences was homologous with mobile genetic elements (56%;
Tables 7 and 8) and was variably present in different strains. Especially the subtractions of strains
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HE300 and JS304 resulted in unexpected large number of plasmid-derived sequences (58% and 60%
of the sequences, respectively). This showed that mobile genetic elements, in particular plasmids, are
likely to have a significant impact on the spread of virulence traits throughout the UPEC genomes, and
on the genomic diversity of these strains in general. However, we are left with many questions about
the genomic diversity and its effect on the gene contents or the pathogenic characteristics of each
strain.
A large fraction of the subtraction fragments (25%) had no or only very low (<85%) sequence
homology with known sequences in the public databases (Tables 6 and 8). It is an interesting
speculation that the strain-specific gene fraction of UPEC encodes a number of novel virulence or
fitness determinants or diagnostically important genetic markers associated with the UPEC phenotype.
The most outstanding result of this study was the identification of 14 DNA sequences significantly
more prevalent among ExPEC strains when compared with commensal E. coli isolates. The
identification of new virulence genes in the UPEC pathotype would contribute to our understanding of
how these bacteria cause disease and provide diagnostic tools to distinguish potentially pathogenic
ExPEC strains from their less virulent counterparts.
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4.2  Identification and functional characterization of a plasmid-encoded iroBCDEN
gene cluster (Study I)
In the previous study (II), we analyzed genome sequences of four highly virulent UPEC isolates by
selectively subtracting the chromosomal fraction shared by ExPEC and commensal E. coli. In this
analysis, we searched for novel genomic sequences, which would be preferentially present in ExPEC
but absent from E. coli of fecal origin. This analysis revealed 14 hitherto unknown DNA sequences,
which were significantly associated with the ExPEC phenotype. In the present study (I), we
characterized DNA regions adjacent to the virulence associated subtraction fragment SPL107
originating from the pyelonephritogenic E. coli strain HE300. By construction of a cosmid library,
followed by colony hybridization, selection, and DNA sequencing, a novel virulence plasmid (p300)
was identified, which carried a chromosomal virulence gene island (iroBCDEN) encoding an iron
acquisition system (i.e. siderophore salmochelin and its receptor IroN). The plasmid encoded
iroBCDEN gene cluster was shown to be functional as it promoted uptake of different catecholate
siderophores in a siderophore negative E. coli strain. Moreover, of capital importance is that plasmid
p300, and with it the functional iroBCDEN gene cluster, were shown to be transmissible in E. coli and
to have the potential capacity to spread throughout bacterial populations by conjugation.
4.2.1  Characterization of the cosmid pJS332 sequence
The ExPEC-associated subtraction fragment SPL107 (Table 9) was identified as part of cosmid
pJS332 originating from the pyelonephritogenic E. coli strain HE300. Cosmid pJS332 carried a 32-kb
DNA insert, which appeared to be a composite of genes derived from plasmids of Salmonella sp. and
E. coli, and from GIs of the UPEC strain 536 and the EHEC strain EDL933.
A total of 31 ORFs were identified in the pJS332 sequence (ORFs 1 to 31; Fig. 6). Seven
ORFs had no significant similarity to nucleotide or protein sequences in the public databases, while 24
putative polypeptides were very similar to characterized proteins of S. enterica and E. coli (Table 10).
With regard to the sequence homologies and the G+C contents, the pJS332 sequence exhibited a
modular structure with three distinct regions (regions I to III; Fig. 6). Region I revealed 99%
homology with the S. enterica plasmid R64. These genes encoded components of a putative ABC
transporter system (YcjA, YdaA, IbfA, YdfA, and YdfB) and proteins involved in plasmid
maintenance, transfer, and replication (Mck, Kor, YdiA, and YdjA). The 5'- and 3'- ends of this region
were flanked by sequences highly homologous with E. coli transposons (Fig. 6; Table 10). A total of
11 putative ORFs (ORFs 2 to 13) were identified in this region. Region II harbored ORFs 15 to 20 and
was highly homologous with the chromosomal iroBCDEN gene clusters of the UPEC strains CFT073
and 536 (Russo et al., 2002, Welch et al, 2002). The 5'-border of region II was composed of a
truncated IS carrying ORFs 21 and 22 (Fig. 6; Table 10). Region III extended from ORFs 23 to 31 and
revealed sequences related to ISs and plasmids as well as a number of hypothetical ORFs with no
significant similarity to sequences in the public databases (Table 10). The deduced AA sequence of
ORF 29 (region III) was highly homologous with the Iss virulence determinant of APEC, which is
involved in increased serum resistence and survival of these strains in the chicken respiratory tract
infection model (Tivendale et al., 2004). The subtraction fragment SPL107 used as the initial DNA
probe was localized on non-coding DNA of region III (Fig. 6; Table 9).
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Figure 6. Schematic presentation of the cosmid pJS332 sequence originating from the UPEC strain HE300.
The overall G+C content of the pJS332 DNA insert was 49%, which is about the average for
the E. coli core genome (51%). However, the G+C content differed significantly within the pJS332
sequence (23% to 72%) displaying peaks and troughs. These variations corresponded to different
functional units (e.g. mobile genetic elements and plasmids) indicating a mosaic DNA structure
composed of elements of apparently different origins (Fig. 7).
Figure 7. Schematic presentation of the G+C content variation (%) within the cosmid pJS332 sequence.
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Table 10. BLASTP (NCBI) homology search of the cosmid pJS332 sequence. A total of 31 ORFs were identified in the cosmid pJS332 sequence, which
originated from S. enterica and E. coli plasmids, GIs of UPEC and from additional diverse and unknown sources.
IdentityORF
(gene)
Size
(AA)a
ORF location
(nt)b
Source Protein sequence homology or designation
% AA
Accession
numberc
DNA
probed
1 136 413 E. coli Truncated ORF, TnpA of Tn1721 95 135 P51565
2 107 791-68 S. enterica pR64 YcjA, putative bacterial repressor protein 100 107 BAB91595
3 377 896-2029 S. enterica pR64 YdaA, putative permease 90 377 BAB91596
4 205 2939-2322 S. enterica pR64 YdbA, hypothetical protein 96 205 BAB91597
5 518 4686-3130 S. enterica pR64 IbfA, putative ABC transporter 95 518 BAB91598
6 196 5539-4949 S. enterica pR64 YdeA, hypothetical protein 100 196 BAB91599
7 85 5796-5539 S. enterica pR64 YdfA, putative ABC transporter 100 85 BAB91600
8 712 6150-8288 S. enterica pR64 YdfB, putative ABC transporter 100 712 BAB91601 ydfB
9 133 8851-8450 S. enterica pR64 Mck, involved in coordination of plasmid
replication with cell division
99 133 BAB91602
10 76 9093-8863 S. enterica pR64 Kor, involved in coordination of plasmid
replication with cell division
100 76 BAB91603
11 96 9389-9679 S. enterica pR64 YdiA, 93% identical to protein YebA on
E. coli plasmid F
100 96 BAB91604
12 299 9669-10568 S. enterica pR64 YdjA; 100% identical to protein YebB on
E. coli plasmid F
100 299 BAB91605
13 443 11949-10618 S. enterica pR64 Truncated ORF, PifA, phage T7 exclusion protein 100 443 BAB91606
14 224 12299-12973 IS903 TnpA, transposase of IS903 99 223 AAF30382
15 725 13385-15562 E. coli 536 PAI III IroN, enterochelin and dihydrobenzoic acid
receptor
99 725 CAC43424 iroN
16 318 16563-15607 E. coli 536 PAI III IroE, putative hydrolase 99 318 CAC43425 iroE
17 409 17877-16648 E. coli 536 PAI III IroD, putative ferric enterochelin esterase 99 409 CAC43426 iroD
18 1261 21766-17981 E. coli 536 PAI III IroC, putative ABC transporter 99 1261 X16664
19 371 22895-21780 E. coli 536 PAI III IroB, UDP-glucoronosyl and UDP-glucosyl
transferase
100 371 X16664
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20 89 23363-23094 No homology Hypothetical protein
21 173 24692-24171 E. coli K5 Hypothetical protein, putative integrase 59 100 CAA54707
22 96 25164-24874 E. coli K5 Hypothetical protein 59 48 CAA54710
23 97 26026-25733 E. coli Hypothetical protein 80 76 AAB40752
24 102 26347-26039 E. coli 102 Iss, increased serum survival and complement
resistance
100 102 AAD41540 orf24
25 80 26948-26706 E. coli EDL933 Hypothetical protein 100 26 AE005326
26 112 26959-27297 E. coli Putative transposase of IS2 98 109 P51026
27 263 27404-28195 E. coli Putative integrase of IS2 97 262 P51026
28 54 28530-28366 Y. enterocolitica Hypothetical protein, trp1328 on IS1328 63 50 CAB46575
29 397 29418-30611 E. coli CFT073 Hypothetical protein, putative cobalamin synthesis
protein
65 397 NP_753181 Porf29
30 103 30750-31061 S. flexneri Hypothetical protein, putative integrase 59 82 NP_709264
31 207 31248-31869 S. enterica pHCM1 Truncated ORF, HCM1.201, putative transposase 95 207 NP_569402
a Predicted polypeptide size (AA)
b Location of a gene on the cosmid pJS332 sequence (nt)
c Accession number of the respective homologue
d DNA probes used in dot blot and DNA microarray analyses (Studies II and IV). The DNA probe homologous with ydfB was excluded from the DNA microarray analysis.
Extraintestinal pathogenic Escherichia coli Results and discussion
49
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki
4.2.2  Identification of the conjugative plasmid p300 carrying iroBCDEN gene cluster
Region I of pJS332 displayed sequences highly homologous with the S. enterica plasmid R64, which
suggested a plasmid origin of the DNA inserted into this cosmid (Table 10). We affirmed that pJS332
originated from a novel 79-kb plasmid denoted as p300, which conferred resistance to trimethoprim,
streptomycin, and tetracycline. Plasmid p300 isolated from the UPEC strain HE300 was transformed
into the E. coli laboratory strain S17-1λPIR, which carried a chromosomal transfer region required for
the conjugative transfer of plasmids (Alexeyev and Shokolenko, 1995). From this strain, p300 was
further mobilized into the E. coli laboratory strain Th2 by mating.
In this study, we showed that the conjugative transfer of the iroBCDEN gene cluster-carrying
plasmid p300 was highly efficient in E. coli. This and the fact that plasmid p300 seemed to originate
from the S. enterica plasmid R64, supported the possibility that plasmid p300 is transmissible by
conjugation into commensal and pathogenic bacteria such as E. coli and S. enterica. It is also likely
that this plasmid transfer will occur naturally, for example in the gut environment, and thus can play
an important role in the spread of virulence and drug resistance factors among E. coli and related
bacteria.
4.2.3  Distribution of the p300-derived sequences among ExPECs and commensal E.
coli isolates
To determine the distribution of the plasmid-carried iroBCDEN gene cluster among ExPECs, dot blot
hybridizations were performed using DNA probes homologous with iroN (region II) and ydfB (region
I; Table 10). The iroN sequence was found in 29 out of 50 ExPEC strains studied (58%). The DNA
probe homologous with the S. enterica plasmid pR64 (ydfB) was identified in six ExPEC strains
(12%). Only two strains were positive for both iroN and ydfB. This data demonstrated that the
iroBCDEN gene cluster described in this project was not liked to the plasmid p300 in the vast majority
of UPEC strains, but rather was chromosomally located or at least linked to a different genetic
backbone.
4.2.4 Functional characterization of the iroBCDEN gene cluster encoded by the
plasmid p300
To investigate the function of the plasmid encoded iroBCDEN gene cluster, the ability of this gene
cluster to promote uptake of catecholate siderophores enterochelin and 2,3-dihydroxybenzoyl-D-
ornithine was tested by a plate assay. We showed that complementation of the siderophore-negative E.
coli strain H5058 with iroN, but not with iroB, iroC, iroD, or iroE was sufficient to promote the
siderophore uptake by this siderophore-negative E. coli strain (Fig. 8). This confirmed that plasmid
p300-encoded IroN functions as receptor for siderophores enterochelin and 2,3-dihydroxybenzoyl-D-
ornithine.
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Figure  8. The feeding bioassay (plate assay) to detect the function of plasmid encoded IroNp300. The E. coli
[fepA cir fiu aroB] mutant strain H5058 complemented with iroNp300 (p[iroNE], p[iroN-iroE:tpr]),
but not with iroBCDE (p[iroBCDE], p[iroN:tpr-iroE]) was able to utilize the catecholate
siderophores enterochelin and 2,3-dihydroxybenzoyl-D-ornithine as sole iron sources. Bacteria
were grown in an iron minimal medium where the growth was visible as halos surrounding the
disk plates soaked into enterochelin or 2,3-dihydroxybenzoyl-D-ornithine.
4.2.5 Virulence determinants are effectively transferred in, between, and from the
ExPEC pathogroup through conjugation
In this study, a novel 75-kb virulence plasmid from an UPEC strain was partially sequenced and
analyzed, providing new insights into molecular mechanisms underlying the dispersion of virulence
factors among UPEC. This plasmid, p300, contained a chromosomal virulence gene cluster
iroBCDEN, which has been shown to contribute significantly to the virulence of UPEC and NMEC in
vivo (Hantke et al., 2003; Negre et al., 2004; Russo et al., 2002). It also carried resistance against three
antibiotics. Furthermore, plasmid p300 was shown to be transmissible by conjugation.
Sequence differences of individual ORFs located in the plasmid p300 suggested that various
regions of this plasmid had different origins; this plasmid encoded genes highly similar to a
chromosomal PAI, transmissible plasmids of S. enterica, as well as to a number of other mobile
genetic elements. This indicated that pathogenic ExPEC isolates might evolve gradually under
selective pressure of the host environments by adopting genetic elements, such as plasmids and PAIs,
from closely and distantly related species. In addition, mobile genetic elements, such as phages,
transposons, and ISs , might be involved in this process either directly by transferring genetic material
or indirectly by providing substrate for the homologous recombination (Kuzminov, 1999).
Recently, a number of ExPEC virulence factors (e.g. salmochelin, aerobactin, and
yersiniabactin siderophore systems as well as the Hbp protease homologue Tsh) have been identified
in APEC, an E. coli subgroup very closely resembling ExPEC (Janben et al., 2001; Rodriguez-Siek et
al., 2005; Tivendale et al., 2004). Several of these virulence determinants in APEC are localized on
large transmissible plasmids similar to plasmids pR64 of S. enterica and p300 described in this study
(Dozois et al., 2003; Gyohda et al., 2004; Johnson et al., 2004; Johnson et al. 2005e; Rodriguez-Siek
et al., 2005). Interestingly, plasmids have been shown to be transferable from poultry to human E. coli
isolates (Johnson et al., 2005e; Levy et al., 1976).
iro BCDE
2,3-dihydroxybenzoyl
-D-ornithine
enterochelin
p[iroNE] p[iroBCDE] p[iroN:Tpr-iroE] p[iroN-iroE:Tpr]
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These results support our data of the novel urovirulence plasmid p300, and indicate that
conjugative transfer is indeed an important means of transfer of virulence factors in UPEC. This
transfer is likely to occur both in natural environments and in the host (e.g. in the gut). Co-localization
of virulence factors and antibiotic resistence genes on the same transmissible plasmid may promote
selection of E. coli containing such plasmids in humans and animals treated with antibiotics (Levy et
al., 1976; Laporta et al., 1986; Johnson et al., 2005e). In this scenario, virulence factors are readily
transferred through plasmids not only between ExPEC strains but also between ExPECs and their
close relatives, such as APEC, enhancing the virulence of infecting pathogens in general. Furthermore,
this also suggest that farm animals colonized with E. coli carrying p300 -like plasmids may serve as a
reservoir of resistance and virulence genes for other bacteria of animal and human health importance.
Further studies of UPEC plasmids, such as p300, should facilitate identification of factors responsible,
in part, for the ExPEC gene transmission and pathogenicity.
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4.3 Characterization of four novel DNA sequences of the UPEC strain JS299 highly
associated with the extraintestinal virulent phenotype (Study III)
In this study, we investigated the genetic information encoded by the nonhomologous fraction of the
UPEC strain JS299 genome. Furthermore, we examined whether these sequences might be a source
for horizontal gene transfer and for generation of genomic diversity in ExPEC. Sequencing and
comparison of four cosmid sequences, JS448, JS666, JS700, and JS706, identified both common E.
coli and Shigella sp. sequences as well as for strain JS299 unique ORFs, suggesting that individual
cosmids expressed distinct features. From database comparisons, we identified putative genes involved
in the regulation of conjugative transfer (finO, sfh), genes found in genomic islands of UPEC (orf44 of
PAI II536) and in the chromosome of EPEC as well as gene sequences homologous to that of an operon
present in the EPEC strain T19 responsible for sucrose utilization. Most unexpected, the scr gene
cluster of cosmid pJS706 had the same organization as the corresponding chromosomal genes of strain
T19, which suggested an exchange of gene clusters between chromosomes of EPEC and UPEC.
The epidemiological distributions of 17 novel cosmid-derived DNA sequences were
determined among ExPEC and commensal E. coli. From this, 13 sequences were found at significantly
higher prevalence among pathogenic isolates and thus could be suitable as new genetic markers for
ExPEC isolates. Interestingly, obtained segregation patterns of DNA probes excluded the genetic
linkage of different genetic modules, which provided new insights into assembly of the UPEC and the
ExPEC genomes in general.
4.3.1  Sequence analysis of the cosmids pJS448, pJS666, pJS700, and pJS706
The ExPEC-associated subtraction fragments SPL341, SPL395, SPL359, and SPL373 (Table 9),
which were derived from the highly virulent UPEC strain JS299, were found in four distinct cosmid
sequences pJS448, pJS666, pJS700, and pJS706 (Table 11). DNA regions neighboring these
subtraction fragments were partially sequenced by primer walking, which revealed DNA sequences of
3200 nt to 6100 nt (Fig. 9 to 12; Table 11). Separate cosmid regions differed markedly in their
respective nucleotide compositions; the G+C contents of distinct cosmid inserts varied not only from
the average G+C content of the E. coli chromosome, but also between the adjacent ORFs (29 to 61%;
Table 11.). A total of 19 ORFs were identified, 12 of which were highly homologous with
hypothetical genes of diverse E. coli and Shigella spp. strains. The remaining seven ORFs had no or
only very low homology (<85%) with the sequences in the public databases (Table 11). Figure 9
shows the partially analyzed cosmid sequences (pJS448 [Fig. 9a], pJS666 [Fig. 9b], pJS700 [Fig. 9c],
and pJS706 [Fig. 9d]). Subfigure A illustrates the variation of the G+C content in a cosmid sequence
(EMBOSS; http://emboss.sourceforge.net). Additionally, subfigure B shows the compositionally
different DNA regions, which are denoted by roman numbers and separated by vertical dotted lines.
Predicted ORFs are marked as arrows showing the direction of translation. Black arrows mark the
conserved E. coli core genome, gray arrows represent the DNA regions specific for a certain E. coli or
Shigella strain, and white arrows mark the unique DNA sequences of the UPEC strain JS299. The
hatched boxes highlight DNA regions with similar genetic composition. Black bars below the genes
show the location of DNA probes used in the DNA microarray analysis (Study IV). The significance
of association with the extraintestinal virulent phenotype (Chapter 4.4.2) is given in parenthesis.
Significant association with the ExPEC phenotype (P<0.05) is indicated with an asterisk.
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The subtraction fragment SPL341 was identified on cosmid pJS448 (Fig. 9a; Table 11). The
5'-boundary of the inserted DNA of pJS448 was highly homologous with the E. coli core genome
(yicO; NC_000913; Fig. 9a). In contrast, the 3'- end of pJS448 had sequences similar to the recently
characterized Type I site-specific restriction-modification system of S. boydii (hsdR;
NZ_AAKA01000002; Fig. 9a). Analysis of the 5363-nt DNA insert of pJS448 revealed a mosaic
structure of three different DNA regions with regard to the genetic configuration, the sequence
homology, and the G+C contents (regions I, II, and III; Fig. 9a). Five putative protein coding genes
(ukoA [unknown ORF; ORF1], ukoB [ORF2], ukoC [ORF3], ukoD [ORF4], and ukoE [ORF5]) located
in this sequence, showed polypeptides similar to proteins involved in regulatory functions as well as to
proteins previously identified in mobile genetic elements (Table 11). Interestingly, the 5'-truncated
ukoA (region I) was identical with the 3'-end of a hypothetical gene located on PAI II of the UPEC
strain 536 (orf44; AJ494981; Fig. 9a, Table 11).
Figure 9a. Schematic presentation of the partial cosmid pJS448 sequence originating from the UPEC strain
JS299.
The subtraction fragment SPL395 was localized on cosmid pJS666 (Fig. 9b; Table 11). The 5'-
end of pJS666 revealed sequences highly homologous with the E. coli core genome (ppdB;
NC_000913; Fig. 9b). The 3'- sequence of the inserted DNA in pJS666 disclosed the 3'- border of the
characterized 4960-nt sequence read (Fig. 9b). Cosmid pJS666 was assembled of three
compositionally different DNA regions (regions I, II, and III; Fig. 9b). Regions I (ukoF [ORF1], ukoG
[ORF2]) and III (ukoJ [ORF5]) were highly homologous with the genomic DNA of EPEC. However,
region II was unique for the UPEC strain JS299. This region was composed of two ORFs (ukoH
[ORF3] and ukoI [ORF4]), which encoded putative proteins without any considerable sequence
identities to known sequences in the public databases (Fig. 9b; Table 11). The G+C content of pJS666
varied from 10% to 87% with observed peaks and troughs that corresponded to different regions (Fig.
9b).
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Figure 9b. Schematic presentation of the partial cosmid pJS666 sequence originating from the UPEC strain
JS299.
The subtraction fragment SPL359 was located on cosmid pJS700 (Fig. 9c; Table 11). The 5'-
and 3'- boundaries of the inserted DNA of pJS700 were highly homologous with the E. coli core
genome (katE, sppA; NC_000913; Fig. 9c). The 3229-nt sequence of pJS700 revealed a duplication of
two DNA fragments (direct repeats 1 and 2; Fig. 9c). Three putative ORFs were identified in the
pJS700 sequence (the 3'- truncated c2163JS299' [ORF1], c2163JS299 [ORF3], and ukoK [ORF2]; Fig. 9c).
The two intact ORFs (c2163JS299 and ukoK) located in this sequence encoded hypothetical proteins
predictably involved in protein-protein interactions (pfam06251; Table 9c). Interestingly, the degree of
homology with known sequences differed within the c2163JS299 sequence; the 5'-end of c2163JS299
shared 95% AA sequence identity with its homologue c2163 in the UPEC strain CFT073, whereas AA
residues at the 3'- end of c2163JS299 were only 36% identical to the respective parts of protein
c2163CFT073 (Table 11). The composite structure of c2163JS299 was also reflected by a decrease of the
G+C content from 46% (nt 1 to nt 600) to 34% (nt 601 to nt 1092; Fig. 9c).
Figure 9c. Schematic presentation of the partial cosmid pJS700 sequence originating from the UPEC strain
JS299.
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The subtraction fragment SPL373 was identified on cosmid pJS706 (Fig. 9d; Table 11). The
5'- and 3'- boundaries of pJS706 were homologous with the E. coli core genome (pyrG, ygbO;
NC_000913; Fig. 9d). The characterized 6183-nt DNA region of pJS706 had G+C content of 47% and
could be divided into regions I (ygcF) and II (scrR, scrB, scrA, and scrY; Fig. 9d). Region I (ygcF) was
conserved among E. coli, Shigella spp., and Salmonella sp. ORFs scrR to scrY (region II) were highly
homologous (99%) with a recently described scr gene cluster encoding a novel sucrose utilization
system in the EPEC strain T19 (Fig. 9d; Table 11; Cowan et al., 1991; Gosset, 2005). The border of
regions I and II was marked by a 59- nt AT-rich sequence (Fig. 9d). Interestingly, highly similar
sucrose-utilizing systems (i.e. scr gene clusters) have been identified also in other enteric bacteria,
such as K. pneumoniae and Salmonella sp. In Salmonella, the conjugative plasmid pUR400 confers
the ability to utilize sucrose, whereas the scr regulon of K. pneumoniae is located on the chromosome
(Sprenger et al., 1988; Wohlhieter et al., 1975).
Figure 9d. Schematic presentation of the partial cosmid pJS706 sequence originating from the UPEC strain
JS299.
In summary, comparison of the four novel cosmid sequences showed that there is substantial
genomic variation among UPEC isolates, particularly in the strain specific gene pool of the genome. In
addition, we observed modular genomic structures with insertion of sequence elements of apparently
different origins. This indicated the existence of a “mix- and match” -combinatorial system, which
might contribute to the high level of genome plasticity among ExPEC.
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Table 11. BLASTN (NCBI) homology search of the cosmid pJS448, pJS666, pJS700, and pJS706 sequences. A total of 19 ORFs were identified, which were
derived from genomes of E. coli and S. flexneri and from additional diverse and unknown sources.
IdentityORF
(gene)
Size
(AA)a
ORF location
(nt)b
G+C
%
Source Protein sequence homology or designation
% AA
Accession
numberc
DNA
probed
Cosmid pJS448
1 (ukoA) 19 1-58 53 E. coli 536 Truncated ORF, Orf44, hypothetical protein of
PAI II
100 58 CAD42059 P700
2(ukoB) 114 179-520 52 E. coli ECOR27 FinO, bacterial conjugation repressor 33 82 AAC44278 -
3 (ukoC) 145 1414-1848 36 S. flexneri Sfh, H-NS–like protein 46 78 AAN38840 P765
4 (ukoD) 190 2265-2834 37 E. carotovora ECA0829, putative membrane protein 51 159 YP_048939 SPL341
5 (ukoE) 418 2935-4188 43 V. cholerae Deoxyguanosine-triphosphate
triphosphohydrolase –related protein
50 406 AAF96216 P774
P767
6 (int) 289 4318-5184 55 S. flexneri S1093, integrase of IS3 100 287 NP_836727 -
Cosmid pJS666
1 (ukoF) 354 1062 61 E. coli E22 EcolE2_01003258, hypothetical protein 96 307 ZP_00728432 P792
2 (ukoG) 405 1014-2228 56 E. coli E22 EcolE2_01003259, hypothetical protein 96 391 ZP_00728433 SPL346
3 (ukoH) 307 2485-3405 31 E. coli CFT073 C1890, hypothetical protein 31 181 NP_753788 SPL395
4 (ukoI) 263 3490-4278 34 E. coli CFT073 C1889, hypothetical protein 34 64 NP_753787 P763
5 (ukoJ) 184 4271-4822 45 E. coli E22 EcolE2_01003260, hypothetical protein 80 172 ZP_00728434 P776
Cosmid pJS700
1 (c2136'-) 197 593 45 E. coli CFT073 Truncated ORF, C2163, hypothetical protein 87 197 NP_754057 -
2 (ukoK) 282 621-1466 40 Magnetococcus sp. COG0790, TPR repeat protein 35 237 ZP_00291368 P785
SPL359
3 (c2136) 364 1478-2569 40 E. coli CFT073 C2163, hypothetical protein 64 360 NP_754057 P769
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Cosmid pJS706
1 (ygcF) 204 1-611 51 E. coli CFT073 Truncated ORF, YgcF, hypothetical protein 92 202 NP_755213 -
2 (scrR) 279 696-1531 46 K. pneumoniae ScrR, sucrose utilization repressor protein 79 221 CAA47977 P780
3 (scrB) 470 1729-3137 49 E. coli T19 ScrB, sucrose 6-phosphate hydrolase 99 338 CAG25843 SPL373
4 (scrA) 457 3137-4507 46 E. coli T19 ScrA, sucrose and maltose specific permease of
the PTS system
92 456 CAG25844 P761
5 (scrY) 506 4568-6086 48 E. coli T19 ScrY, sucrose and maltose porin 89 359 CAG25845 P762
a Predicted polypeptide size
b Location of an ORF in a cosmid sequence
c Accession number of the respective homologue
d DNA probe used in the DNA microarray analysis
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4.3.2 Association of the novel DNA sequences with the ExPEC phenotype
Since sequence data does not provide adequate information on the epidemiology of novel DNA
sequences of the UPEC strain JS299, we determined the distribution of 15 previously uncharacterized
cosmid-associated genes (17 DNA probes) in a group of clinical ExPECs and commensal E. coli
isolates by means of DNA microarray analyses (Studies III and IV).
In the ExPEC population, these DNA probes ranged in prevalence from less than 20% (scrY,
ukoC, ukoD/E, ukoE1, ukoK, and ukoK/c2163) to more than 60% (ukoA and ukoF; Table 12). In total,
13 out of 17 novel DNA sequences were found at significantly higher frequency (P<0.05) among
ExPEC isolates when compared to commensal E. coli strains isolated from stool samples (Table 12).
These DNA probes included one DNA fragment targeting the pJS448 sequence (ukoE; Fig. 9a), five
probes marking the pJS666 sequence (ukoF, ukoG, ukoH, ukoI, and ukoJ; Fig. 9b), three DNA
fragments specific for genes c2136 and ukoK located on the cosmid pJS700 sequence (Fig. 9c) and
finally, four DNA fragments homologous with the scr gene cluster of cosmid pJS706 (scrA, scrB, scr
and scrY; Fig. 9d). Of note, the scr gene cluster was explicitly found in ExPEC strains, as all E. coli
strains isolated from stool samples failed to hybridize with the pJS706-specific DNA probes (Table
12). Interestingly, the obtained hybridization patterns of distinct genes differed significantly among
cosmid sequences. For example, the unique genes ukoC, ukoD, and ukoE of cosmid pJS448, ukoH,
and ukoI of cosmid pJS666 as well as the scr gene cluster of pJS706 showed a pattern of segregation
different of that in surrounding sequences.
Here we presented 13 novel DNA sequences originating from an UPEC strain that are highly
associated with the ExPEC phenotype, and which may serve as new genetic markers for ExPEC
isolates. In addition, the data of this study suggested that the analyzed cosmid sequences were
genetically flexible and thus they might segregate independently of one another. In the future,
expression- and function studies of the novel genes described here should provide evidence of whether
these clusters of hitherto unknown genes contribute to the UPEC pathogenesis.
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Table 12. Prevalence of 17 cosmid-associated DNA sequences among ExPECs and commensal E.
coli isolates.
DNA microarray probe ExPEC
n=53
(Prevalence%)
Commensal E. coli
n=37
(Prevalence%)
Pa
Cosmid pJS448
P700 (ukoA) 34 (64%) 17 (46%) 0.067
P765 (ukoC) 7 (13%) 1 (3%) 0.089
SPL341 (ukoD/E) 8 (15%) 1 (3%) 0.058
P767 (ukoE1) 7 (13%) 1 (3%) 0.089
P774 (ukoE2) 15 (28%) 2 (5%) 0.007*
Cosmid pJS666
P792 (ukoF) 47 (89%) 22 (59%) 0.002*
SPL346 (ukoG) 20 (38%) 2 (5%) 0.001*
SPL395 (ukoH) 16 (30%) 1 (3%) 0.001*
P763 (ukoI) 16 (30%) 1 (3%) 0.001*
P776 (ukoJ) 18 (34%) 2 (5%) 0.002*
Cosmid pJS700
P769 (c2136) 18 (34%) 5 (14%) 0.026*
P785 (ukoK) 7 (13%) 0 (0%) 0.029*
SPL359 (ukoK/c2136) 7 (13%) 0 (0%) 0.029*
Cosmid pJS706
P780 (scrR) 12 (23%) 0 (0%) 0.002*
SPL373 (scrB) 11 (21%) 0 (0%) 0.004*
P761 (scrA) 12 (23%) 0 (0%) 0.002*
P762 (scrY) 10 (19%) 0 (0%) 0.007*
a The significance of association with the ExPEC phenotype was determined by a DNA microarray analysis. Using the χ2
test, a P value of <0.05 was considered as statistically significant. The significant association is indicated with an asterisk.
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4.3.3 The impact of metabolic functions on the ExPEC virulence
In this study, we argue that resolving the molecular mechanisms of sugar metabolism, in particular
sucrose and its regulation might provide an important theme for investigating the host-pathogen
interactions in intestinal and extraintestinal environments. We identified an E. coli sucrose specific
phosphotransferase system (the scr gene cluster of cosmid pJS706) of UPEC, which was found in 20%
of the clinical ExPEC isolates but in none of the commensal E. coli strains studied (Fig. 9d).
Interestingly, this gene cluster was highly homologous (>90%) with the previously described scr
operon of EPEC.
The impact of metabolic functions on E. coli pathogenesis became evident in the past decades,
when effective iron acquisition systems were shown to be required for the bacterial virulence (Bullen
et al., 2005). More recently, evidence has been accumulated that besides iron utilization other
metabolic functions may also account for the ability of E. coli strains to colonize and infect a host. For
instance, the ability to use deoxyribose of degraded DNA or mucosal saccharides, such as gluconate,
N-acetylglucosamine, and mannose, as carbon sources enables E. coli effectively colonize the mucous
surfaces of the intestine (Bernier-Febreau et al., 2004; Chang et al., 2004). In addition, metabolic
genes may not only be involved in the accumulation of limited nutrients, but may also be implicated in
the regulation of virulence factors. The catabolic enzyme D-serine deaminase (DsdA) of UPEC has
been shown to modulate growth and gene expression (e.g. flagella) in response to the urinary D-serine
levels and thus influence the E. coli uropathogenesis (Roesch et al., 2003). The finding of an ExPEC-
associated sucrose utilization gene cluster presented in our study was unexpected, as less than 50% of
the E. coli strains are able to use sucrose as the sole carbon source (Cowan et al., 1991). As the scr
gene cluster described here was explicitly detected in clinical E. coli isolates, we hypothesize that
sucrose metabolism may play a role in the ExPEC fitness or infectivity. This role could be mediated
either directly by conferring upon the pathogen the ability to use this nutrient or indirectly as a
mediator of regulatory functions. However, the results presented here must be considered with certain
caution, as we provided no data considering the prevalence of the scr gene cluster among intestinal
pathogens, such as EPEC, Shigella spp., or Salmonella sp. In addition, there are yet no studies
available regarding the impact of sucrose catabolism on the extraintestinal virulence or colonization.
Nevertheless, the detection of metabolic genes highly associated with the ExPEC phenotype may
further emphasize a causal relationship between nutritional factors and the pathogenesis of ExPEC.
4.3.4 The “puzzle theory”: UPEC genomes are mosaics of individual genetic modules
of different origins
The sequences derived from the genome of the UPEC strain JS299 revealed complex mosaic
structures (Study III). These mosaics were assembled of compositionally different, short DNA
modules integrated into the common E. coli backbone (Fig. 9). The novel genes were characterized by
atypical G+C contents (Table 11), which indicated a foreign origin of these DNA sequences (Sharp
and Li, 1987; Wang et al., 2001). In addition, the distinct cosmid-associated genes exhibited divergent
patterns of distribution among ExPECs (Table 12), which excluded the genetic linkage of individual
DNA modules.
As ExPEC have shown to inhabit widely diverse niches, such as the gut, the vagina, and the
urinary tract (Johnson et al., 1998; Siitonen et al., 1992), adaptation to the changing environments
might be the driving force for the genetic variation in these strains. However, the mechanisms leading
to the diversification of the ExPEC genomes are largely unknown. The UPEC sequences described in
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this study showed genetically flexible modular structures, “gene puzzles”, which might enable
integration or deletion of genetic modules. This makes such non-conserved gene islands ideal
candidates for an efficient adaptation mechanism in ExPEC. The possibility to combine a gene or a
domain from one gene with another gene, some regulatory element (e.g. promoter or transcriptional
regulator), or different genetic background (e.g. plasmid) might produce chimeric genes and gene
islands that demonstrate unexpected functional properties. The advantage of such a modular
organization is somewhat obvious; ExPEC could obtain and distribute a high number of diverse
genetic modules in and from E. coli and other bacterial populations. Different combinations of
modules could have been created by recombination (deletion and insertion) and selected for by the
needs of ExPECs in their individual hosts. Due to the modular structure, ExPEC might either pick up
chromosomal genes of other organisms or integrate sequence modules from foreign plasmids, which
are taken up by the bacteria during their natural transformation competence. From conjugative
plasmids, such as p300 (Study I), the novel sequences could be rapidly distributed within the UPEC
and other ExPEC populations, and exchange novel plasmid-carried sequences with the bacterial
chromosomes. Such events might help to explain the vast diversity among ExPEC strains and their
ability to effectively colonize and inhabit different anatomical sites and hosts (e.g. domestic animals
and humans).
The “puzzle theory” was further supported by a finding of novel DNA sequences derived from
UPEC that were highly homologous with the genomic DNA of enteropathogenic E. coli (Table 11).
Moreover, these new DNA sequences had a significant association with the extraintestinal virulent
phenotype (Table 12). Interestingly, although EPEC and UPEC strains infect anatomically and
therefore physiologically different body sites (i.e. the intestine and the urinary tract, respectively),
some virulence determinants, such as the cytotoxic necrotizing factors and the Afa/Dr family adhesins,
are shared by both pathotypes (Bouguenec and Servin, 2006; Nougayrede et al., 2005). Many of the
potential virulence factors in both intestinal and extraintestinal pathogenic E. coli are encoded by
mobile genetic elements, including plasmids, PAIs, and bacteriophages, and the association between
DNA transfer and virulence is well documented (Hacker and Carniel, 2001; Ochman et al., 2005). The
identification of ExPEC-associated sequences common to two pathotypes is a further indication of the
dynamic and extensive DNA exchange, which continuously remodels genome contents of pathogenic
E. coli.
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4.4 Development and validation of a clinical DNA microarray specific for ExPEC
causing UTIs (Study IV)
ExPEC are intestinal commensals as well as pathogens of the urinary tract and other extraintestinal
sites. Due to the extreme heterogeneity of the UPEC and the ExPEC populations in general, routine
surveillance of these pathogens is very difficult. A number of phenotypic and genotypic methods,
including serotyping, ribotyping, phylogenetic typing, and virulence gene typing, have been developed
to detect and categorize virulent ExPEC clones (Bingen-Bidois et al., 2002; Clermont et al., 2000;
Clermont et al., 2001; Morin and Hopkins, 2002). Although these DNA-based methods have been
useful for the identification of ExPEC strains, they are limited in that they identify only a few kinds of
strains (e.g. according to the serotype, the phylogenetic group, or a limited number of virulence genes)
at a time and thus do not often correlate to the virulence of ExPEC strains. Because common clinical
ExPECs belong to a wide range of serotypes as well as possess numerous virulence genes and genetic
markers, the aforementioned methods cannot meet the requirement of quick and simultaneous
identification of various ExPEC clones.
In this study, we describe a sensitive and specific method for rapid and accurate
identification of clinical and resident ExPECs within a single DNA microarray (“ExPEC pathoarray”).
This pathoarray was composed of 44 PCR probes homologous with known ExPEC virulence genes
encoding toxins, proteases, iron acquisition systems, and adhesion factors. Additional 33 PCR probes
represented putative markers of the ExPEC phenotype, which in part, were identified during this
project. These probes included hypothetical genes located in GIs of UPEC (Study III) and the
virulence plasmid p300 (Study I) as well as a number of ExPEC associated subtraction fragments
(Study II). Chromosomal DNA of E. coli isolates (target DNA) was labeled with the fluorescent dye
Cy5-dCTP.
As the obtained information volume of the ExPEC pathoarray described here would be largely
inapprehensible for routine diagnostic laboratories, the array was combined with a novel virulence
gene algorithm (VGA) for estimation of the extraintestinal virulence potential (VP, pathogenicity risk)
of clinically relevant ExPECs and fecal E. coli isolates. Performance of the ExPEC pathoarray was
tested by estimating VPs of a number of known and unknown ExPECs (n=53) and commensal E. coli
strains (n=37; Table 14). Furthermore, relations of the VPs, clonal origins (i.e. phylogenetic groups),
clinical data, and virulence gene profiles of distinct strains were determined. We showed that both the
ExPEC pathoarray and the VGA described in this study could be employed for detection and
classification of unknown ExPEC strains both in epidemiological surveys and in routine diagnostics.
4.4.1 The prevalence of indicator genes among clinical ExPECs and commensal E. coli
Applicability of the ExPEC pathoarrays was validated using 90 clinical and commensal E. coli strains,
which were isolated in hospitals in Finland or Germany (Table 14). In ExPEC strains investigated,
DNA probes ranged in prevalence from less than 30% (e.g. the Afa/Dr adhesins, cytotoxic necrotizing
factors, and S fimbriae) to more than 70% (e.g. the yersiniabactin siderophore receptor FyuA and Auf
fimbriae; Study IV). Of the 77 DNA probes included on the pathoarray, 61 sequences were identified
as good indicators of the extraintestinal virulent phenotype (i.e. were associated with ExPEC isolates;
P<0.05). These probes included 25 PCR fragments homologous with known ExPEC virulence factors
(e.g. toxins, adhesins, and siderophore receptors; Fig. 10) and 36 PCR fragments homologous with
putative virulence determinants (e.g. hypothetical ORFs associated with GIs of UPEC; Fig. 11). The
discriminative power of individual DNA probes between the extraintestinal virulence and the
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commensalisms was expressed as the “correct classification rate”, and varied from less than 0.3 (e.g.
subtraction fragments SPL135 and SPL345 (Study II), which were associated with the commensal E.
coli phenotype) to more than 0.7 (e.g. the known ExPEC virulence determinants aufA, aufG, chuA,
fyuA, iroD, iroE, iroN, iucC, papF, papGII, prfG, prrA, and usp; Fig. 10). This value characterized the
potential of a single gene to represent the extraintestinal virulent phenotype. Classification rates close
to one corresponded to nearly perfect indictors, whereas rates closer to zero indicated indifferent genes
(i.e. not representative of the ExPEC phenotype). Interestingly, none of the ExPEC-associated
indicator genes could be uniformly detected in all ExPEC strains or in an ExPEC subgroup (e.g.
according to the clonal origin or the clinical signs caused).
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Prevalence of the indicator
genes among ExPEC and
commensal E. coli isolates. 25
PCR probes homologous with
the known ExPEC virulence
factors were significantly
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4.4.2  Development and validation of the virulence gene algorithm for differentiation
and classification of clinical ExPECs and fecal E. coli isolates according to their
extraintestinal virulence potentials
In order to concretely describe the pathogenicity risk (i.e. the capacity to cause an infection) of an
ExPEC isolate, the extraintestinal virulence potentials of ExPEC and commensal E. coli strains were
calculated using a novel “virulence gene algorithm” (VGA). The VGA was based on the assumption
that the virulence of ExPEC strains would be strongly dependent upon the available virulence gene
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repertory and that the extraintestinal virulence potential of an E. coli strain could be estimated
according to the assortment of these virulence genes (i.e. indicator genes; Figs. 10 and 11). The VGA
was based on logistic regression analysis, which modeled the extraintestinal virulence by virtue of the
co-occurrence of individual DNA probes (Hartigan and Wong, 1979).
Applicability of the VGA was validated by determining the correlation between clinical data,
phylogenetic data, virulence gene repertoires, and the estimated “virulence potentials” (VPs) in the
group of known and unknown clinical ExPECs and commensal E. coli isolates. 85% of ExPECs and
81% of commensal E. coli strains were accurately classified as pathogenic or non-pathogenic
correspondingly to their estimated VPs (Table 14; Fig. 12). In contrast, eight UPEC strains and seven
fecal E. coli isolates must be reclassified (Table 14; marked with an asterisk). Review of the clinical
data and the virulence gene profiles of these strains warranted the estimated VPs. The UPEC strains
with atypically low risk-ratios (VP<0.5) were largely isolated from patients with predestined medical
history, such as diabetes or urinary-catheter, or from patients with advanced age. The ExPEC have
shown to effectively colonize the bowel (Jantunen et al., 2001; Nowrouzian et al., 2005; Siitonen,
1992) and thus the fraction of rectal E. coli isolates with the VPs characteristic of ExPEC (VP>0.5)
was likely to represent this diagnostically important fraction of resident, potentially pathogenic strains
deposited in the gut. Although ExPEC strains are normal inhabitants of the intestinal flora, the fecal
and vaginal colonization with ExPEC might predispose towards UTI especially in susceptible patients
(Foxman and Brown, 2003). Furthermore, the results obtained from this study correlated with previous
research projects and further emphasized the opportunistic nature of UTIs caused by UPEC (Gordon et
al., 2005).
Figure 12. Estimation of the extraintestinal virulence potential of unknown ExPECs (n=53) and commensal
E. coli (n=37) isolates using the VGA (VP<0.5 = low virulence, VP ≈ 0.5 = opportunistic
virulence, VP>0.5 = high virulence). A large fraction of ExPEC strains (79%) displayed VPs
highly characteristic of the extraintestinal virulent phenotype (0.7 to 1.0). In contrast, 6% of
clinical ExPEC strains showed moderate VPs of 0.6 to 0.7 and 15% of the ExPEC strains were
classified according to their VPs (0.2 to 0.5) as non-pathogenic. 81% of commensal E. coli isolates
showed VPs less than 0.3. Two commensal E. coli strains had VPs of 0.5 to 0.6 and five fecal E.
coli strains showed VPs highly indicative of the ExPEC phenotype (VPs of 0.7 to 1.0).
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Table 14. Evaluation of the extraintestinal virulence potential of clinical ExPECs and fecal E. coli
isolates using the VGA developed in this project.
E. coli strain Clinical characteristic(s) PGa VPb
ExPEC
536 Pyelonephritis B2 0.92
AD110 Cystitis B2 0.97
CFT073 Pyelonephritis B2 0.97
CP9 Bacteriemia B2 0.99
D9 Cystitis A 0.77
Do764 Cystitis B2 1.00
Do768 Cystitis B2 1.00
ED2403 Cystitis A 0.37*
HE300 Pyelonephritis A 0.95
IHE1041 Pyelonephritis B2 0.90
IHE1049 Pyelonephritis B2 0.93
IHE1086 Pyelonephritis B2 0.79
IHE11015 Pyelonephritis B2 0.82
IHE11020 Pyelonephritis B2 0.98
IHE11035 Pyelonephritis A 0.48*
IHE11048 Pyelonephritis B2 0.84
IHE11158 Pyelonephritis B2 0.95
IHE11290 Pyelonephritis B2 0.90
IHE1167 Pyelonephritis B2 0.97
IHE1190 Pyelonephritis B2 0.99
IHE1210 Pyelonephritis B2 0.89
IHE1402 Pyelonephritis B2 0.97
IHE1431 Pyelonephritis B2 0.77
IHE3034 Newborn meningitis B2 0.85
IHE3040 Newborn meningitis B1 0.77
IHE3041 Newborn meningitis B2 0.98
IHE3047 Newborn meningitis B2 0.87
IHE3080 Newborn meningitis B2 0.85
J96 Pyelonephritis B2 0.95
JS293 Chronic cystitis,
host suffers of diabetes mellitus
B2 0.44*
JS295 Cystitis B1 0.35*
JS297 Cystitis,
host suffers of diabetes mellitus
B2 0.85
JS299 Cystitis B2 0.98
JS304 Pyelonephritis B1 0.67
JS305 Pyelonephritis B2 0.95
JS309 Cystitis B2 0.98
JS322 Pyelonephritis D 0.44*
JS323 Pyelonephritis B2 0.24*
JS325 Pyelonephritis B2 0.86
JS326 Pyelonephritis B2 0.66
JS355 Pyelonephritis B2 0.92
Nu14 Cystitis B2 0.81
RS218 Newborn meningitis B2 0.97
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S2207 Catheter-associated cystitis A 0.27*
S2265 Catheter-associated pyelonephritis B2 0.97
S2287 Catheter-associated pyelonephritis D 0.88
S2288 Catheter-associated pyelonephritis B1 0.41*
S2413 Urosepsis B2 1.00
S2523 Urosepsis B2 0.83
S2536 Urosepsis D 0.95
S2572 Urosepsis D 0.87
S2608 Cystitis A 0.74
S27710 Pyelonephritis B2 0.62
Commensal E. coli
BL21 Laboratory strain A 0.05
DH5α Laboratory strain A 0.08
DSM6601 Stool B2 0.98*
ECOR31 Stool D 0.19
HB101 Laboratory strain A 0.09
MG1655 Stool A 0.08
S4000 Stool D 0.09
S4005 Stool B1 0.17
S4010 Stool B2 0.63*
S4011 Stool B2 0.21
S4012 Stool A 0.27
S4013 Stool D 0.35
S4014 Stool D 0.34
S4015 Stool B1 0.11
S4016 Stool B1 0.06
S4017 Stool B1 0.09
S4020 Stool B2 0.93*
S4021 Stool B2 0.98*
S4022 Stool D 0.52*
S4023 Stool A 0.27
S4026 Stool A 0.13
S4039 Stool B1 0.79*
S4050 Stool B1 0.74*
S4134 Stool A 0.12
S4136 Stool A 0.18
S4138 Stool A 0.09
S4140 Stool A 0.12
S4141 Stool A 0.07
S4147 Stool B1 0.11
S4148 Stool A 0.15
S4149 Stool B2 0.24
S4151 Stool B1 0.07
S4152 Stool A 0.19
S4153 Stool B1 0.11
S4158 Stool B1 0.11
TOP10 Laboratory strain A 0.07
XL-1 Blue MRF´ Laboratory strain A 0.24
a Phylogenetic group (PG) was defined using the DNA probes described by Clermont et al., 2000.
b The extraintestinal virulence potential was defined using the virulence gene algorithm. The strains with an atypical VP are
indicated with an asterisk.
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4.5 Future aspects: preventative screening of ExPECs in patient groups
susceptible of life-threatening extraintestinal infections (Studies I to IV)
E. coli is the predominant facultative anaerobe of the human colonic flora and most strains are
harmless. However, certain E. coli strains cause extraintestinal diseases in humans. These infections
caused by ExPEC account for serious morbidity and mortality in the elderly, in young children, and in
immune-compromised and hospitalized patients (Foxman and Brown, 2003). ExPEC strains are
heterogeneous both with respect to symptoms developed by infected hosts and with respect to
virulence genes (Foxman et al., 2000; Gaynes and Edwards, 2005). Currently available diagnostic
tools for extraintestinal infections have low sensitivity and specifity, and often provide no accurate
information about the different serovars of ExPEC (Bingen-Bidois et al., 2002; Clermont et al., 2000;
Clermont et al., 2001; Morin and Hopkins, 2002). The present major focus in the research of
extraintestinal infections is to discover gene loci that are conserved among ExPEC, and may provide
genetic markers for a broad range of ExPEC.
In the current project, we identified 61 potential indicator genes of the extraintestinal virulence
using literature search (Study IV), subtractive genomic hybridization (Study II), genetic
characterization of plasmid- and chromosome-borne virulence genes (Studies I and III), DNA
microarray analyzes (Studies I, III, and IV), and bioinformatics (Study IV). These candidate genes not
only included known virulence determinants of ExPEC (n=25), but also a number of novel DNA
sequences (n=36) with only a putative function in the ExPEC virulence. As none of these genetic
markers was present in all ExPEC isolates studied here, these molecular probes per se could not be
used in routine clinical laboratory testing for identification of different ExPEC serovars. Consequently,
we assessed the strains’ extraintestinal virulence potential globally using a novel virulence gene
algorithm, which based on the co-occurrence of all analyzed sequence probes (Study IV). To our
knowledge, this study described for the first time the application of the DNA microarray technology in
combination with a quantification method for the rapid and reliable detection of ExPEC strains.
To validitate the method described here, we carried out molecular typing for a collection of 53
ExPECs and 37 fecal E. coli isolates. As the microarray combined with the VGA was able to detect
and clearly identify the ExPEC isolates, this system offered an interesting potential for clinical
microbiology laboratories. With the development of more aggressive therapeutic regimens, the
incidence of multiresistant ExPEC strains has increased (Johansen et al., 2006; Paterson, 2006). The
early initiation of accurate antibiotic therapy is critical in reducing the high mortality rates of
susceptible patients due to extraintestinal infections. However, this is only possible if the pathogen is
identified early and accurately. The previously described molecular methods for ExPEC diagnosis
feature only limited multiplexing capability, resulting in time delay and high costs if all relevant
variants must be considered (Bingen-Bidois et al., 2002; Clermont et al., 2000; Clermont et al., 2001;
Morin and Hopkins, 2002). An economically more efficient approach would be the application of a
protocol, which is capable of identifying a panel of relevant characteristics (e.g. virulence and
antibiotic resistance genes) in a parallel fashion. For example, the standard methods to detect antibiotic
resistances in pathogenic E. coli isolates take more than one day. Using the microarray technology in a
combination with a highly sensitive and selective PCR system, the assay time could be reduced for a
few hours. Simultaneously the sensitivity and the specificity would be increased, which are the most
important factors for a clinical application (Bruant et al., 2006 Cassone et al., 2006). Furthermore,
identification of pathogenic or multiresistant E. coli strains in the mixed culture samples (e.g. in the
urine and the stool samples, or in the biofilms on the catheter surfaces) could be possible (Kostic et al.,
2007; Maynard et al., 2005). Besides the clinical diagnostics of acute infections, the analysis on the
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molecular level could be used for the long term monitoring of patients with indwelling catheters or
during an antibiotic treatment. Here, we described such an ExPEC identification array by making use
of the high multiplexing capacity of DNA microarrays. The fact that highly virulent ExPEC isolates,
which carry a perilous configuration of extraintestinal virulence factors, could be effectively
differentiated from less pathogenic clinical ExPECs and from commensal E. coli strains opened up
new avenues for the acute and the preventive diagnostics. By manifolding the scarce target sequences
in a clinical sample using an elaborate PCR amplification (e.g. random extension of genomic DNA
sequences followed by the target-directed amplification) prior to microarray analysis, it might be
possible to circumvent laborious and time-consuming bacterial cultivation and DNA isolation
procedures, and thus provide a system suitable for routine use.
In summary, DNA microarrays, such as the ExPEC pathoarray described here, present a
promising platform for the parallel identification virulence factors and the detection of genes that
confer antibiotic resistance. However, to our knowledge, there are no such commercial arrays
available so far, and thus this topic provides an interesting issue for future applications for
optimization of diagnostics of microbial infections.
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5. CONCLUSIONS AND FUTURE PERSPECTIVES
This project was initiated to characterize the genomic variation of ExPEC; a diverse group of E. coli
strains infecting extraintestinal sites, such as the bloodstream, the meninges, and the urinary tract.
During this project, genomic sequences of three E. coli strains (i.e. the UPEC strain CFT073, the
commensal E. coli strain MG1655, and the EHEC strain EDL933) and two closely related S. flexneri
strains became available (Blattner et al., 1997; Jin et al., 2002; Perna et al., 2001; Welch et al., 2002;
Wei et al., 2003). The accumulated sequence data as well as data obtained from further research
projects have aided to compile a portrait of the ExPEC pathogroup. Accordingly, the ExPEC genomes
are extremely dynamic and differ considerably with regard to their sizes, the gene contents, and the
number of known virulence factors (Dobrindt and Hacker, 2001; Johnson and Russo, 2005
Oelschlaeger et al., 2002). Therefore, in spite of best efforts, no research team has managed to
decipher the genes or factors, which are uniformly required by ExPEC or by some ExPEC subgroup to
initiate or establish an infection. These strains have obtained a significant proportion of their genetic
diversity through acquisition of DNA from related or non-related organisms. Different mobile genetic
elements, such as phages, transposons, plasmids, and PAIs are involved in this horizontal gene transfer
(Hacker and Carniel, 2001; Ochman et al., 2005). However, it is known neither how these very
dynamic genomes have been assembled or controlled, nor which mechanisms are responsible for the
observed genomic mobility.
Our results corroborate the previous genomic studies, which document high genomic
variability among the ExPEC pathogroup and strongly emphasize the impact of lateral gene transfer as
the driving force in shaping the ExPEC genomes (Dobrindt and Hacker, 2001; Hacker and Carniel,
2001). We showed that ExPEC strains are different, not only from commensal E. coli strains
belonging to the normal intestinal flora, but from also each other. This extensive variation was not
restricted to distinct ExPEC subgroups (e.g. NMEC or UPEC) as also UPEC strains studied differed
significantly from each other with respect to their genomic contents and the virulence gene repertoires.
A large fraction of the UPEC genomes (up to 25%) seems to be composed of unique DNA without any
known sequence counterpart or function. Given that the amount of transferred strain-specific DNA in
ExPEC can only be estimated, it is likely that yet unknown virulence or fitness factors are encoded by
the unique DNA fraction. The fact that not many virulence factors are common in UPEC strains was
unexpected since all UPEC strains cause the same disease. Our findings imply that a number of
alternative virulence factors can mediate each step in the infection process and that each strain may
have a unique combination of such factors. Detection of novel ExPEC-associated DNA sequences in
UPEC, shared by both intestinal pathogenic and extraintestinal pathogenic E. coli, further emphasized
the importance of understanding the mechanisms and the environmental signals UPEC use for
recognition of environmental changes and different ecological niches (e.g. the gut and the urinary
tract).
An assortment of virulence genes is apparently made possible by a variety of genetic factors,
which contribute to the genomic plasticity. The novel ExPEC-associated DNA sequences
characterized in this project revealed composite DNA structures of unknown genes and mobile genetic
elements of different origins, such as pathogenicity islands, insertion sequences, transposable
elements, phages, and plasmids. The presence of such mobile elements adjacent to virulence gene
clusters has previously been described in another contexts and it has been suggested that these
sequences mediate the mobilization of the respective chromosomal gene clusters (Dobrindt et al.,
2002; Neilands, 1992; Purdy and Payne, 2001). This project provided circumstantial evidence that IS
elements indeed facilitate site-specific recombination events and in this manner enable the transfer of
single genes or gene clusters from their original locations to new sites. As follows, we assumed that
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the integration of IS elements in the sites adjacent to a chromosomal iroBCDEN gene cluster led to its
mobilization into S. enterica plasmid, an event which resulted the novel urovirulence plasmid p300.
However, the sole presence of mobile elements did not explain the mosaic DNA structures
characteristic of the novel DNA sequences originating from the UPEC strain JS299. These sequences
displayed short, compositionally different DNA fragments, which showed individual patterns of
distribution among ExPEC strains. It appeared likely that also homologous recombination, even within
coding genes, contributed to the observed mosaicism in ExPEC, and that besides en block transfer of
large DNA regions (e.g. iroBCDEN cluster of plasmid p300) rearrangements of small DNA modules
might also provide a means of genomic plasticity. Interestingly, sequences highly homologous with
the genomic islands of the archetypal UPEC strains showed that even parts of such supposedly inert
virulence gene clusters could be mobilized individually. An additional and important conclusion from
this data was the indication that the conjugative transfer of plasmids provides indeed means for
effective lateral gene transfer in ExPEC strains. The accumulation of virulence factors and antibiotic
resistance genes on the same horizontally transferable vehicle may lead to the simultaneous transfer of
multiple virulence and antibiotic resistance determinants to further bacterial strains, species, or genera.
Many of the sequences examined in this project were of genes that had an unknown function
or no known homologues in the public databases, but which were significantly associated with the
extraintestinal virulent phenotype. Although we did not attribute functions to these novel genes in the
present project, they do represent novel markers for urovirulence, which are well suited for the
subclassification and subtyping ExPECs and other E. coli isolates. Subsequent studies will have to
define the function of these novel determinants on the ability of ExPEC strains to colonize and infect
the urinary tract in order to decipher the puzzle of ExPEC virulence.
In the last part the project, we demonstrated that highly virulent ExPEC isolates, which carry a
perilous configuration of extraintestinal virulence factors, could be effectively differentiated from less
pathogenic clinical ExPECs and from commensal E. coli strains. This was achieved using a novel
ExPEC pathoarray combined with a virulence gene algorithm, which described the potential of a
certain gene combination to present the extraintestinal virulent phenotype. The preventive diagnostics
of extraintestinal infections is of great interest especially in immunocompromised subjects susceptible
to severe life-threatening infections (e.g. diabetic or elderly patients, neonates, or pregnant women) or
in patients treated at the intensive care units with invasive interventions (e.g. the urinary catheter). The
exact knowledge of the genotype (e.g. antibiotic resistence) of a clinical sample, would allow
purposive prevention in a sufficient time. We show that diagnostic microarrays provide better and
more rational use of available resources of the public health care by focusing on target-directed
prevention (i.e. targeted treatment according to the known genotype of an infecting strain), instead of
massive therapeutic interventions of these life-threatening infections.
In summary, this project has attempted to make clear that genomics (i.e. DNA sequencing of
partial and entire E. coli genomes) and rapid screening methods, such as the DNA microarray
analyses, have deepened our appreciation of genetic diversity and horizontal gene transfer as central
features of the ExPEC pathogroup. In addition, we argue that unraveling the molecular mechanisms of
gene transfer and its regulation provides a unifying theme for investigating the host-pathogen
interactions in a wide range of extraintestinal infectious diseases.
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8. APPENDICES: Original publications
